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Abstract 
 
Horses are at high risk to develop systemic inflammation due to the release of bacterial 
endotoxin from an inflamed gastrointestinal tract. Neutrophils are critical for mounting an 
immune response to bacterial endotoxins. Neutrophil activation following engagement of 
bacterial endotoxin expands their lifespan through suppression of their constitutive apoptosis. 
The prolonged lifespan of neutrophils propagates acute inflammation and delays the resolution of 
inflammation.  Since equine neutrophil lifespan has not been well-studied, I investigated the 
occurrence of equine neutrophil apoptosis in vitro and in vivo.   
 First, I investigated the effect of Escherichia coli lipopolysaccharide (LPS) treatment on 
the occurrence of equine neutrophil apoptosis in vitro.  LPS treatment delayed in vitro equine 
neutrophil apoptosis in a dose-dependent manner at concentrations of 0.1-10 μg/ml through toll-
like receptor (TLR)-4 signaling and down-regulation of the intrinsic pathway of apoptosis, 
specifically through reduced caspase-9 activity.  
 Next, I found that ex vivo neutrophil apoptosis was delayed in two models of intestinal 
inflammation, jejunal ischemia and reperfusion (IR) and oligofructose-induced colitis, through 
down-regulation of both the intrinsic and extrinsic apoptosis pathways via reduced caspase-3, -8, 
and -9 activities. Pulmonary intravascular macrophages (PIMs) depletion with systemic 
gadolinium chloride (GC) prevented the prolongation of ex vivo neutrophil lifespan in horses 
undergoing jejunal IR through modulation of caspase-3, -8 and -9 activities. PIM depletion in IR 
horses resulted in an earlier and greater increase in tumor necrosis factor-alpha and a 
concomitant decrease in interleukin-10 to suggest an enhanced systemic pro-inflammatory 
response.  
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I examined the effect of neutrophil concentration and co-incubation with aged, apoptotic 
neutrophils on the occurrence of neutrophil apoptosis in vitro.  Neutrophil apoptosis was delayed 
with increasing concentrations of neutrophils in vitro, which may contribute to delayed 
neutrophil apoptosis in systemic inflammation.  However, co-incubation with aged, apoptotic 
neutrophils did not alter in vitro neutrophil lifespan. 
Taken together, the data show that LPS delays equine neutrophils apoptosis in vitro in a 
TLR4-dependent manner through inhibition of caspase-9. Ex vivo neutrophil apoptosis was also 
delayed with systemic inflammation via down-regulation of caspase activity. A novel finding of 
this work was the reversal of delayed neutrophil apoptosis by depletion of PIMs in horses 
experiencing intestinal IR. 
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Chapter 1: Review of the Literature 
1.1 Introduction 
The innate immune response has evolved to effectively handle immediate threats, be it 
pathogenic or physical, to the body.  Upon introduction of a foreign entity, immune cells within 
the vicinity recognize the threat using pattern-recognition receptors (PRR), such as Toll-like 
receptors (TLR), and initiate a coordinated response to neutralize the threat. Neutrophils serve as 
one of the primary effector cells of this immediate immune response. They may be activated by 
cytokines and chemokines released from resident macrophages, or primarily activated through 
PRRs. Upon activation, they are involved in neutralizing pathogens via phagocytosis and 
oxidative burst.  They also potentiate the immune response by releasing cytokines and 
chemokines to attract more immune cells, primarily neutrophils, into the area. 
As a sequela to activation by various stimuli, neutrophil life span is prolonged (Savill et al. 
2002).  Normally, neutrophils are short-lived cells, undergoing constitutive apoptosis at the end 
of their lives followed by their removal via phagocytosis by macrophages residing in the spleen, 
liver, and bone marrow (Akgul et al. 2001, Jia et al. 2008, Edwards et al. 2004, Tak et al. 2013).  
Prolongation of neutrophil lifespan conserves the neutrophil population in times of need, such as 
during sepsis, but at the same time can prove detrimental due to the non-specific method by 
which neutrophils neutralize threats through the release of histotoxic contents that induces 
further inflammatory cell infiltration (Colotta et al. 1992, Jia et al. 2008, Milot et al. 2012, Sano 
et al. 2005, Savill et al. 2002, Sweeny et al. 1998, Yamamoto et al. 1993). Additionally, the 
phagocytosis of apoptotic neutrophils causes the polarization of macrophage phenotype from an 
inflammatory to anti-inflammatory (Fadok et al. 1998, Huynh et al. 2002, Lucas et al. 2003).  
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Taken together, delayed neutrophil apoptosis contributes to the potentiation of an inflammatory 
response, possibly to the detriment of the body. 
Targeting neutrophil apoptosis may prove to be an effective mechanism to control acute 
inflammation and promote healing during multiple disease processes; but before neutrophil 
apoptosis is used as a therapeutic target, the mechanisms by which neutrophil apoptosis is 
delayed in various situations must be understood. 
1.2 Constitutive neutrophil apoptosis  
 
Apoptosis is also defined as programmed cell death and involves various cellular pathways that 
ultimately cause nuclear DNA fragmentation and cessation of cellular processes without 
disturbing tissue homeostasis. There are two classical cellular pathways by which a cell may 
undergo apoptosis.  The extrinsic pathway involves activation of membrane receptor proteins by 
an extracellular signal, such as tumor necrosis factor-alpha (TNF-α) or Fas ligand, that initiates a 
cascade of enzymatic reactions that are propagated by proteases called initiator caspases (e.g. 
caspase-8).  Alternatively, the intrinsic pathway involves an intracellular signal, such as 
irreparable damage to DNA or severe cell stress, which changes the balance of the B cell 
lymphoma (Bcl)-2 family of proteins to increase mitochondrial permeabilization, allowing 
release of cytochrome c into the cytosol and activation of the apoptosome and initiator caspase-9.  
The extrinsic and intrinsic pathways are also linked through activation of the pro-apoptotic Bcl-2 
homology-3-interacting domain death agonist protein (Bid) by caspase-8.  As a final step in both 
pathways, the effector caspases, caspase-3, -6, and -7, enter the nucleus and cause DNA 
fragmentation leading to characteristic changes in nuclear morphology including karyorrhexis 
and pyknosis (Savill et al. 1989, Kamada et al. 2005).  The effector caspases also activate 
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proteins that dissemble components of the cytoskeleton, such as actin, resulting in cell shrinkage 
and blebbing (Brown et al. 1997, Knepper-Nicolai et al. 1998).   
Neutrophils undergo constitutive apoptosis via the intrinsic pathway at the end of their 
normal lifespan without the influence of extracellular signals (Akgul et al. 2001, Fox et al. 2010).  
Neutrophil lifespan is thought to be regulated by the balance between pro-apoptotic and anti-
apoptotic proteins of the Bcl-2 family (Figure 1.1), particularly myeloid cell lymphoma (Mcl)-1 
(Fox et al. 2010, Edwards et al. 2004).  In homeostatic conditions, there is a greater 
concentration of pro-apoptotic proteins compared to anti-apoptotic proteins to result in a 
shortened life span (Akgul et al. 2001).  The phosphoinositide 3-kinase (PI3K) and mitogen-
activated protein kinase (MAPK) signalling pathways are thought to play a role in regulation of 
Bcl-2 protein production through nuclear factor kappa (NFκ)-B activation, accounting for 
changes in neutrophil lifespan during inflammatory conditions (Akgul et al. 2001).   
The Bcl-2 family of proteins is responsible for maintaining mitochondrial membrane 
potential.  There are two arms to this protein family.  One arm promotes apoptosis and includes 
Bid protein, Bcl-2 associated X protein (Bax), Bcl-2 homologous antagonist/killer protein (Bak), 
Bcl-2-associated death promoter protein (Bad), Bcl-2 interacting protein (Bim), and Bcl-2 killer 
protein (Bik).  The other arm prevents apoptosis and includes Bcl-2, Bcl-xL, Mcl-1, and A1. In 
human neutrophils, Mcl-1 has been identified as the most important inhibitor of neutrophil 
apoptosis, especially in response to LPS treatment as discussed later in this review (Edwards et 
al. 2004, François et al. 2005, Wardle et al. 2011). The apoptotic state of a neutrophil relies on 
the balance of these proteins. In normal neutrophils, anti-apoptotic proteins have a rapid turnover 
compared to the pro-apoptotic proteins, which tends to keep the balance shifted toward 
apoptosis, making neutrophil lifespan relatively short (Geering and Simon 2011).  With the 
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balance in favor of the pro-apoptotic members of the Bcl-2 family, mitochondrial membrane 
potential is lost leading to the release of cytochrome c into the cytosol and activation of the 
apoptosome, apoptotic protease-activating factor 1 (Apaf-1), and caspase-9 that initiates caspase-
3 to induce apoptosis.  Neutrophil mitochondria are unique in that they are primarily involved in 
death-mediated processes, and less so in energy production (Maianski et al. 2004).   It has been 
demonstrated that neutrophils may undergo caspase-9 activation and subsequent apoptosis, 
independent of mitochondrial permeabilization and cytochrome c activation of the apoptosome 
as part of an alternative intrinsic pathway, which may also contribute to their relatively short 
lifespan compared to other leukocytes (Maianski et al. 2004).   
Cell death by apoptosis provides a means by which a cell may die while maintaining the 
integrity of its membrane, thereby preventing the release of its cellular contents.  Once a 
neutrophil has become apoptotic, its membrane undergoes changes, such as externalization of 
phosphatidylserine, to provide a signal to professional phagocytic cells, namely macrophages, to 
remove it from the circulation or tissue (Savill and Fadok 2000).  Macrophages are then able to 
recognize apoptotic neutrophils and phagocytose them prior to the release of their histotoxic 
contents (Savill et al. 1989).  Interestingly, CD14, a surface molecule traditionally involved in 
LPS activation of TLR4, is important for tethering non-inflamed apoptotic cells to macrophages 
during the course of phagocytosis (Devitt and Marshall 2011).  
Concomitantly, neutrophil function is abrogated upon the induction of apoptosis. The 
neutrophil cytoskeleton is disabled as a result of apoptosis in order to maintain cell shape and 
prevent de-granulation and chemotaxis (Whyte et al. 1993, Brown et al. 1997).  Respiratory burst 
and phagocytic functions are also impaired (Whyte et al. 1993).  A hallmark of delayed 
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neutrophil apoptosis is the ability for neutrophils to maintain their capacity for effector functions, 
such as respiratory burst (Koedel et al. 2009, Watson et al.1997). 
Another set of cytosolic proteases, called calpains, have also come under investigation for 
their role in constitutive neutrophil apoptosis.  Calpains are regulated by intracellular calcium 
concentration and act as non-specific proteases to cleave target proteins that are involved with 
maintaining and regulating cytoskeleton structure (Knepper-Nicolai et al. 1998).  Indeed, it has 
been shown that calpains are involved in multiple processes of neutrophil apoptosis including the 
processing of Bax, alteration of nuclear morphology, and phosphatidylserine exposure (Knepper-
Nicolai et al. 1998, Geering and Simon 2011).  Inhibition of calpain activity is associated with 
delayed neutrophil apoptosis (van Raam et al. 2008).  Cathepsins are another type of protease, 
located in neutrophil granules, which are involved in apoptotic processes including the 
processing of caspase-8 and Bid that ultimately leads to activation of caspase-3 (Geering and 
Simon 2011).  Recently, another cytosolic protease called serine protease proteinase 3 (PR3) was 
identified as playing a key role in caspase-3-dependent constitutive apoptosis of human 
neutrophils in vitro independent of caspase-8 or caspase-9 activation (Loison et al. 2014). 
Neutrophils have other unique apoptotic pathways compared to other cells.  Traditionally, 
tumor necrosis factor (TNF)-α initiates apoptosis via the extrinsic pathway.  In neutrophils, this 
holds true for early or high concentration TNF-α exposure (Fox et al. 2010, Murray et al. 1997, 
Salamone et al. 2001).  Additionally, exposure to high concentrations of TNF-α reduces Mcl-1 
through increased turnover to induce apoptosis (Cross et al. 2008).  However, late survival (after 
12 h) is promoted simultaneously through activation of the NF-κB pathway and subsequent up-
regulation of the anti-apoptotic members of the Bcl-2 family, particularly A1 (Cross et al. 2008). 
Another unique contribution to neutrophil apoptosis involves reactive oxygen species (ROS) that 
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are produced by the neutrophils themselves upon TNF-α stimulation.  It is currently thought that 
most of the molecular pathways causing neutrophil apoptosis are dependent upon ROS 
generation; however, ROS can have alternative effects on neutrophils, such as interference with 
caspase activities causing delayed apoptosis or the initiation of cell necrosis rather than apoptosis 
(Fadeel et al. 1998, Geering and Simon 2011, Scheel-Toellner et al. 2004). 
In conclusion, constitutive neutrophil apoptosis is not as straight-forward as other cell 
types, likely involving alternative pathways to the classically described pathways of apoptosis.  
Consequently, the process by which neutrophils undergo apoptosis is still under investigation in 
all species.  Additionally, the process by which extravasated neutrophils undergo apoptosis in 
tissues remains largely unknown (Tak et al. 2013). 
1.3 Models used to evaluate neutrophil apoptosis: in vitro and in vivo  
 
Thus far, the most common method utilized to evaluate neutrophil apoptosis has been culturing 
isolated neutrophils in vitro.  However, when evaluating neutrophil physiology in vitro, it is 
essential to create standard culture conditions due to the highly reactive nature of this cell type.  
One troublesome contaminant of neutrophil processing and culture is bacterial endotoxin, a 
substance that is ubiquitous in the environment and that requires additional steps to remove 
compared to traditional sterilization methods.  The variability in results reported in the literature 
from studies on neutrophils is potentially due to unintentional activation with substances, such as 
LPS (Haslett et al. 1985).  However, neutrophils can also become activated by seemingly 
innocuous stimuli, including changes in temperature, pipetting, and isolation technique (Freitas 
et al. 2008, Hannah et al. 1998, Haslett et al. 1985, Tennenberg et al. 1988, Watson et al. 1992). 
Similar to other immune cells, functional in vivo studies on neutrophils are traditionally 
performed using knockout mice.  Genetically modified mice have been used to evaluate the 
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contribution of various components of the known apoptosis pathways.  For example, knockout 
mice for the various Bcl-2 family of proteins have been used to assess the relative importance 
and redundancy of each protein (Geering and Simon 2011).  Though mice models are invaluable 
for studying cellular pathways, it must be understood that these models are substantially removed 
from the physiology of wild type mice or other species.  Antibodies and silencing RNA may be 
used to selectively knockout proteins or genes in cells from non-laboratory animals to further 
study cellular pathways. 
Studies have also been performed using humans and animals with known genetic defects 
of leukocytes, such as human chronic granulocytic leukemia and bovine leukocyte adhesion 
deficiency (Hasegawa et al. 2003, Naghata et al. 2004).  Studies are also commonly performed 
using neutrophils isolated from humans and animals suffering from clinical diseases that involve 
neutrophil activation (Jimenez et al. 1997, Krista et al. 2013, McCracken and Allen 2014).   
Overall, models that use clinical disease are useful in evaluating neutrophil physiology and 
lifespan; however, the use of control neutrophils from normal humans and animals for 
comparison is less than ideal as there is significant variation among neutrophil response by 
individual (first author’s unpublished observation). 
1.4 Inflammatory mediators that delay neutrophil apoptosis in vitro 
As primary effectors cells of the innate immune response, neutrophils are integral in neutralizing 
pathogenic and non-pathogenic threats to the body. Neutrophils may be activated by a variety of 
substances through PRRs, such as TLRs. PRR activation initiates intra-cellular signaling 
pathways involved in altering cellular processes, including apoptotic pathways, to neutralize the 
perceived threat. Alteration of apoptotic pathways may lead to prolongation of neutrophil 
lifespan via delayed apoptosis. This section will focus on inflammatory mediators that have been 
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identified in causing delayed neutrophil apoptosis in vitro and, if they are known, the proposed 
mechanisms by which these mediators act to delay neutrophil apoptosis. 
Bacterial lipopolysaccharide (LPS) has been evaluated extensively for its effect on neutrophil 
lifespan both in vitro, and to a lesser extent, in vivo.  It has been shown to consistently delay 
neutrophil apoptosis in vitro in multiple species, except the horse (Brazil et al. 2014, Colotta et 
al. 1992, Jia et al. 2008, Milot et al. 2012, Sweeny et al. 1998, Sano et al. 2005, Yamamoto et al. 
1993).  The mechanism of delayed neutrophil apoptosis involves a shifting of balance from pro-
apoptotic to anti-apoptotic processes of the intrinsic pathway of apoptosis via TLR4 activation 
(Edwards et al. 2004, François et al. 2005, Figure 1.1).  Upon TLR4 activation, two interrelated 
intracellular transcriptional pathways have been shown to be involved in LPS-delayed apoptosis 
including the NF-κB and PI3K  pathways (François et al. 2005, Sweeney et al. 1998, Figure 1.1). 
These pathways are involved in regulating the balance of the Bcl-2 family of proteins at the 
transcriptional level.  Specifically, the anti-apoptotic protein Mcl-1 has been shown to be up-
regulated to tip the balance of the Bcl-2 family of proteins into an anti-apoptotic state (Edwards 
et al. 2004, François et al.   2005). Within canine neutrophils, Bcl-xL was identified to be highly 
expressed in neutrophils exhibiting LPS-delayed apoptosis (Sano et al. 2005). 
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Figure 1.1 Potential mechanism of LPS-delayed neutrophil apoptosis 
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Other ligands of TLRs have also been implicated in causing delayed human neutrophil 
apoptosis in vitro (François et al., 2005, El Kebir et al. 2014, Sabroe et al. 2005).  These include 
peptidoglycan (ligand for TLR2), flagellin (ligand for TLR5), R-848 (ligand for TLR7/8), and 
CpG DNA (ligand for TLR9, François et al., 2005, El Kebir et al. 2014, Salamone et al. 2010).  
Similar intracellular signalling pathways are activated compared to TLR4 signaling, resulting in 
increased concentrations of the anti-apoptotic Bcl-2 proteins Mcl-1 and A1 and phosphorylation 
of the pro-apoptotic Bcl-2 protein Bad (François et al., 2005, El Kebir et al. 2014). 
Interleukin (IL)-1β is an important pro-inflammatory cytokine that is produced by 
granulocytes and mononuclear cells upon PRR activation. The production of IL-1β is a caspase-
1-dependent process.  In mononuclear cells, IL-1β production results in cell death via pyroptosis; 
but in neutrophils, IL-1β is produced without inducing pyroptosis (Chen et al. 2014).  
Additionally, IL-1β delays in vitro human neutrophil apoptosis via inhibition of Fas-mediated 
apoptosis by the IL-1β converting enzyme (caspase-1) (Colotta et al. 1992, Tatsuta et al. 1996, 
Watson et al. 1998). 
Other cytokines and growth factors that delay in vitro neutrophil apoptosis include IL-2, IL-
8, TNF-α, interferon (IFN)-γ, granulocyte macrophage colony stimulating factor (GM-CSF), 
granulocyte colony stimulating factor (G-CSF), and complement 5a (Colotta et al. 1992, Fox et 
al. 2010, Lee et al. 1993, Sakamoto et al. 2003).  As discussed previously, TNF-α has variable 
effects on neutrophil apoptosis; however, it apparently increases the occurrence of apoptosis in 
the face of treatment with substances that typically delay neutrophil apoptosis, such as GM-CSF 
(Salamone et al. 2001).  GM-CSF and G-CSF delay apoptosis through modulation of the intrinsic 
pathway of apoptosis as evidenced by reduced cytochrome c release and reduced caspase-3 and -
9 activities (Molloy et al. 2005).  
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Adhesion molecules involved in neutrophil extravasation and activation also play a role in 
determining neutrophil lifespan. Cross-linking of adhesion molecules, such as β2 integrin 
CD11b/CD18, activates neutrophils through outside-in signaling to produce and release ROS and 
myeloperoxidase (MPO).  MPO, in turn, delays spontaneous neutrophil apoptosis via 
stabilization of mitochondria membrane potential and inhibition of the intrinsic pathway of 
apoptosis through ERK 1/2 and Akt signaling pathways (El Kebir et al. 2008), while ROS has 
variable effects on neutrophil apoptosis (Geering and Simon 2011). LPS also up-regulates β2 
integrins, contributing to delayed apoptosis, although cross-linking of β2 integrins alone causes 
delayed apoptosis (Watson et al. 1997).  Alternatively, apoptosis is delayed in neutrophils 
isolated from calves with bovine leukocyte adhesion deficiency that have CD18-deficient 
neutrophils and in CD18 knockout mice, both of which lack the ability to implement β2 integrin  
signaling pathways (Nagahata et al. 2004, Weinmann et al. 2003).  In animals with dysfunctional 
CD18, neutrophils are unable to leave the bloodstream leading to a profound neutrophilia.  It is 
likely that the increased concentration of neutrophils in this scenario is the cause of delayed 
apoptosis rather than a manifestation of the missing receptor (discussed later in this review).  
Another integrin, α9β1 integrin, also delays in vitro neutrophil apoptosis through the PI3K and 
MAPK pathways and NF-κB-dependent increased production of anti-apoptotic protein Bcl-xL 
(Saldanha-Gama et al. 2010). Vitronectin, a component of the extracellular matrix that modulates 
neutrophil adhesion and chemotaxis, also delays neutrophil apoptosis in vitro (Bae et al. 2012).  
Taken together, it is evident that activation of adhesion molecules leads to neutrophil activation 
and delayed apoptosis, which allows the prolongation of neutrophil lifespan as it enters into the 
inflammatory milieu outside of the circulation. 
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Pathogens themselves have a variable effect on human neutrophil apoptosis.  The effect of 
bacteria on neutrophil apoptosis in vitro is dependent upon the bacterial species and strain, 
duration of exposure, multiplicity of infection, and the cell culture conditions (Fox et al. 2010). 
There are at least four possible outcomes following phagocytosis of bacteria by neutrophils.  One 
outcome, which occurs after phagocytosis of most bacteria, results in phagocytosis-induced cell 
death and ROS production where neutrophils undergo apoptosis without releasing their cellular 
contents and are then cleared by macrophages (Kobayashi et al. 2003).  A second outcome, 
which occurs after the phagocytosis of Streptococcus pyogenes by human neutrophils, results in 
rapid neutrophil death via necrosis with limited ROS production leading to pathogen release 
from the neutrophil and its survival (Kobayashi et al. 2003).  A third outcome, which occurs after 
the phagocytosis of Chlamydia pneumoniae by human neutrophils, causes a temporary 
prolongation of neutrophil survival, likely mediated by LPS and IL-8, to allow the intracellular 
pathogen to multiply within the cell; after which time, the neutrophil undergoes apoptosis and an 
unsuspecting macrophage phagocytoses the apoptotic neutrophil with the hidden pathogen and 
polarizes to an anti-inflammatory phenotype (Fox et al. 2010).  A fourth outcome has been 
described after phagocytosis of Staphylococcus aureus, where neutrophil lifespan may be 
prolonged or shortened based on the specific toxins carried by the bacteria (Fox et al. 2010).  
Taken together, it is obvious that neutrophil responses and lifespan may differ significantly by 
pathogen and may not relate directly to what occurs upon exposure to various components of a 
pathogen, such as LPS.  Additionally, the behavior of neutrophils in vivo could potentially have 
even greater discrepancies than what has been observed in vitro. 
 
 
13 
 
1.5 Non-inflammatory causes of delayed neutrophil apoptosis 
From the previous section, it is clear that exposure to inflammatory mediators and substances 
that promote neutrophil activation delay neutrophil apoptosis.  However, the causes of delayed 
neutrophil apoptosis encompass even simpler mechanisms, including concentration- or density-
dependent delayed neutrophil apoptosis, highlighting the highly reactive properties of 
neutrophils and their complex life and death balance. 
A physiologic response to inflammation in the tissues or systemic inflammation is the 
accumulation of neutrophils through increased extravasation and increased release from the bone 
marrow, respectively.  As neutrophils accumulate in tissues or the circulation, their concentration 
increases leading to their delayed apoptosis by a unique mechanism.  This is in direct contrast to 
the majority of cell types that increase their apoptotic rate due to contact inhibition as their cell 
numbers increase.  Overall, there has been very little research into concentration-dependent 
delayed neutrophil apoptosis.  However, an elegant study performed by Attalah et al. (2012), 
demonstrated a clear relationship between increasing neutrophil concentration and delayed 
apoptosis in vitro.  They identified the importance of cytosolic proteins S100A8 and S100A9 as 
having a clear role in delaying neutrophil apoptosis in highly concentrated cell cultures through 
CD11b/CD18 and TLR4 ligation and MAPK pathway activation without up-regulation of anti-
apoptotic Bcl-2 proteins (Attalah et al. 2012).  
Another group previously investigated the effect of neutrophil density and concentration 
on neutrophil lifespan in vitro (Hannah et al. 1998).  This group determined that increased 
density was more influential than increased cell concentration on prolonging neutrophil lifespan 
in vitro, where the rate of apoptosis was inversely proportional to the number of cells per unit 
surface area.  In addition, this group determined that density-delayed apoptosis was independent 
14 
 
of β2 integrin adhesion and that neutrophils did not secrete “survival factors” to delay apoptosis 
in a paracrine or autocrine fashion.  They concluded that localized hypoxia and pH changes 
likely contributed to the effect of density-delayed apoptosis, although these parameters were not 
specifically tested (Hannah et al. 1998).  The concept of concentration- or density-delayed 
neutrophil apoptosis should be considered in any disease process that causes an increase in 
circulating neutrophils, from acute inflammatory diseases to genetic leukocyte adhesion 
deficiency diseases. 
A plethora of substances and culture conditions have been evaluated for their effect on 
neutrophil apoptosis in vitro, but only a selected few that are directly related to inflammation will 
be discussed herein.  Hypoxia delays neutrophil apoptosis through up-regulation of Mcl-1 via the 
p38 MAPK and NF-κB signaling pathways through an unknown receptor (Hannah et al. 1995, 
Leuenroth et al. 2005, Walmsley et al. 2005).  Additionally, neutrophils have a ferroprotein 
oxygen-sensing mechanism, comparable to the mechanism for erythropoietin regulation in 
kidney fibroblasts, which causes up-regulation of hypoxia inducible factor-1 to contribute to 
hypoxia-delayed apoptosis (Mecklenburgh et al. 2002).  Most wounds are considered to be 
hypoxic due to disruption of blood supply. As first responders in the inflammatory response to a 
wound, neutrophils would be exposed to these hypoxic conditions in addition to inflammatory 
mediators, thus prolonging their lifespan and potentially prolonging the inflammatory stage of 
inflammation, which could delay healing.  Therapeutic regimens, such as hyperbaric oxygen 
therapy, have been developed to address the hypoxic conditions within a wound or during 
inflammatory diseases with varying success indicating that the effects of hypoxia during 
inflammatory processes are complex (Kranke et al. 2015). A recent study reported that bovine 
neutrophil apoptosis was enhanced in neutrophils treated with hyperbaric oxygen compared to 
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cells cultured in normoxic and hypoxic conditions in vitro (Almzaiel et al. 2015). Wounds and 
inflammatory environments are also considered to be acidic and acidity (pH 6.5) has also been 
shown to delay neutrophil apoptosis (Negrotto et al. 2006).  Alternatively, alkaline conditions 
promote rapid neutrophil apoptosis in vitro (Leblebicioglu et al. 1999). 
Dexamethasone, a corticosteroid commonly used in veterinary practice, delays neutrophil 
apoptosis in vitro in multiple species via activation of the PI3K and MAPK pathways and up-
regulation of Mcl-1 via NF-κB transcription (Barnes 2011, Brazil et al. 2014, Cox et al. 1997, 
Kettritz et al. 2006, Liles et al. 1995, Marwick et al. 2013, Saffar et al. 2008).  However, the anti-
apoptotic effect of dexamethasone on neutrophil apoptosis is abrogated in hypoxic conditions 
(<1% oxygen tension) to the point that it can rescue hypoxia- and GM-CSF-delayed neutrophil 
apoptosis (Marwick et al. 2013).  This finding may have implications in ischemic disease 
processes that may be treated with glucocorticoids, but are characterized by extensive neutrophil 
accumulation.  Additionally, the ability of glucocorticoids to prolong neutrophil lifespan has 
implications in acute inflammatory diseases where animals become stressed, further exacerbating 
delayed neutrophil apoptosis. 
Similarly, non-steroidal anti-inflammatory drugs (NSAIDs) have also been shown to 
affect neutrophil apoptosis, although relatively few studies are available. Acetaminophen delayed 
human neutrophil apoptosis in vitro (Freitas et al. 2013); however, in another study, ibuprofen 
had no effect on LPS-delayed apoptosis, while aspirin and its metabolite, salicylate, rescued 
delayed neutrophil apoptosis due to multiple conditions including LPS and IL-1α treatment and 
hypoxia (Negrotto et al. 2006).  Furthermore, humans who ingested aspirin had markedly 
reduced ex vivo LPS-delayed neutrophil apoptosis and mice pre-treated with aspirin had 
increased apoptotic neutrophils in their peritoneal cavity after a thioglycolate-induced peritonitis 
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model (Negrotto et al. 2006).  Similarly, pre-treatment with aspirin reduced post-
cardiopulmonary bypass delayed ex vivo neutrophil apoptosis (Bates et al. 2004).  Another study 
evaluating neutrophil apoptosis after treatment with racemic mixtures of various NSAIDs 
demonstrated an increase in neutrophil apoptosis in vitro (Zielińska-Przyjemska et al. 2008). 
 Lastly, and a point of consideration when designing in vivo and ex vivo neutrophil 
experiments, a difference in the occurrence of neutrophil apoptosis has been observed between 
genders in humans (Molloy et al. 2003).  Spontaneous neutrophil apoptosis was reduced in 
women compared to men mediated by estradiol and progesterone reducing cytochrome c release 
from the mitochondria (Molloy et al. 2003).  Female sex hormones have been evaluated for their 
immunomodulatory effects due to the fact that women of reproductive age are less susceptible to 
sepsis and its accompanying complications; however, delayed neutrophils apoptosis would have 
a seemingly negative effect on septic process as discussed in a later section.  
 In conclusion, this section further highlights the complexities of neutrophil lifespan and 
demonstrates that the occurrence of neutrophil apoptosis in disease processes is affected by many 
factors.  When evaluating neutrophil apoptosis in in vivo models, it is important to attempt to 
control for variables that might have a confounding effect on results. 
1.6 Other immune cell involvement in neutrophil apoptosis 
Macrophages play a critical role in managing circulating neutrophil concentration in vivo.  As 
stated previously, macrophages in the spleen, liver, and bone marrow remove apoptotic 
neutrophils from the circulation.  In a mouse model, where mice lacked macrophages in the 
spleen and bone marrow, the clearance of apoptotic neutrophils was delayed causing an 
increased production of G-CSF to drive granulopoiesis and delay neutrophil apoptosis (Gordy et 
al. 2011).  Additionally, when macrophages fail to phagocytose neutrophils in CD18-deficient 
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mice that have delayed neutrophil apoptosis, they produce increased amounts of IL-23 that, in 
turn, drives IL-17-dependent granulopoiesis (Stark et al. 2005).  These responses by 
macrophages could significantly contribute to a neutrophilic response during disease processes 
by increasing neutrophil concentration and further contributing to concentration-delayed 
neutrophil apoptosis. More work is needed to confirm these findings in wild type animals using 
in vivo inflammatory models. 
Macrophages rely on the apoptosis of neutrophils to direct the resolution of inflammation 
(discussed below); however, they also play a key role in the induction of neutrophil apoptosis 
through the release of death receptor ligands, such as TNF-α and Fas-ligand (Brown and Savill 
1999, Meszaros et al. 2000, Salamone et al. 2001).  In a mouse wound model, macrophage-
induced neutrophil apoptosis was dependent upon direct cell-to-cell contact via cell adhesion 
molecules, such as β3 integrin, and membrane-bound, not soluble, TNF-α (Meszaros et al. 2000). 
Similarly, in a mouse model of Leishmania major infection, ex vivo neutrophil apoptosis was 
positively correlated with the amount of co-cultured macrophages and was dependent on 
membrane-bound TNF (Allenbach et al. 2006). 
Although not widely accepted, there is evidence that monocytes are necessary to facilitate 
neutrophils’ responses to LPS, such as delayed apoptosis.  One group reported a difference in in 
vitro LPS-delayed neutrophil apoptosis between isolated neutrophils cultured with and without 
contaminating monocytes (Sabroe et al. 2002).   When monocytes were removed from neutrophil 
isolates via magnetic activated cell sorting, LPS failed to delay neutrophil apoptosis in vitro.  
The results of this study highlight an inherent problem when working with primary isolated cells.  
In general, purities of greater than 90% are considered to be acceptable when working with 
primary isolated neutrophils and the predominant contaminating cell types are other 
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granulocytes, such as eosinophils and basophils.  Regardless, primary cell behavior may be 
altered by minute amounts of contaminating cell types unbeknownst to the investigator. 
A unique type of macrophage, called the pulmonary intravascular macrophage (PIM), 
exists in the capillaries of the alveolar septal in select animals, including the horse (Brain et al. 
1999, Aharonson and Singh 2010).   Similar to Kupffer cells in the liver, PIMs are intimately 
associated with the endothelium of the alveolar capillaries where they phagocytose blood-borne 
foreign substances, pathogens, and apoptotic cells, including neutrophils (Brain et al. 1999).  
Because of their location, they are exposed to the entire blood volume as it passes through the 
alveolar capillaries for oxygen exchange. Therefore, PIMs are potentially influential cells in 
mounting a systemic inflammatory response (Aharonson and Singh 2010).   In vivo studies in 
horses have demonstrated that significant pulmonary injury and inflammation occur in horses 
administered systemic lipopolysaccharide (LPS) and pulmonary intravascular macrophages 
(PIMs) are integral in potentiating these effects in the lung (Parbhakar et al. 2005).  To the 
authors’ knowledge, the involvement of PIMs in the regulation of neutrophil apoptosis during 
inflammatory conditions has not been investigated.  
A recently identified pseudocytokine that is secreted and regulated by activated T 
lymphocytes, called pre-B cell colony enhancing factor, has also been identified for its role in 
inflammation-delayed neutrophil apoptosis (Jia et al. 2004, Sun et al. 2013).  It has since been 
identified in a variety of tissues and cells, including the liver, lung, muscle, and leukocytes (Sun 
et al. 2013).  In addition to its role in the development of B and T lymphocytes, PBEF interacts 
with multiple pro-inflammatory cytokines including IL-1β, IL-6, IL-8, and TNF-α.  It acts on 
cellular processes through the PI3/MAPK pathway and NF-κB activation.  In neutrophils, PBEF 
is synthesized and released upon activation and is associated with reduced caspase-3 and -8 
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activities, not caspase-9, in its role as an inhibitor of neutrophil apoptosis (Jia et al. 2004).  
Additionally, it is highly expressed in neutrophils isolated from septic human patients (Jia et al. 
2004). 
1.7 Apoptosis of neutrophils is required for the resolution of inflammation 
One of the key elements of the inflammatory process is the ability for the immune system to 
switch from a pro-inflammatory state to and an anti-inflammatory state, thereby bringing about 
the resolution of inflammation and the initiation of healing.  Macrophages are considered to be 
the orchestrators of this process.  A fundamental signal for a macrophage to initiate the 
resolution of inflammation is to phagocytose apoptotic neutrophils.  As discussed above, when 
an inflammatory process proceeds in an ideal manner, neutrophils undergo apoptosis after 
phagocytosing a pathogen or at the end of their short lifespan.  Once neutrophils undergo 
apoptosis, they send out “eat me” signals or apoptotic cell-associated molecular patterns, 
attracting macrophages to them and initiating the process of efferocytosis (Savill et al. 1989).  
These signals involve changes in the neutrophil cell membrane, such as phosphatidylserine 
translocation to the outer leaflet of the plasma membrane, and may be modulated by charged 
glucose and amino acid molecules or pH (Fadok et al. 1992, Frasch et al. 2011, Huynh et al. 
2002, Savill et al. 1989).  A recent study identified the down-regulation of a surface receptor, 
CD47 as a signal for apoptotic neutrophil phagocytosis (Lawrence et al. 2009). Apoptosing 
neutrophils can express “find me” signals to attract macrophages, including 
lyophosphatidylserine, annexin-1, thrombospondin 1, and soluble IL-6R, or macrophages can 
secrete molecules to attract apoptosing neutrophils, such as MFG-8E (Silva 2011).  The process 
by which apoptotic neutrophils and macrophages communicate to cause efferocytosis is still 
under investigation. 
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Macrophages bind to apoptotic neutrophils through bridging molecules, such as 
thrombospondin 1 via specific surface molecules, which have not been fully identified (Savill 
and Fadok 2000).  A recent study identified the mechanism by which efferocytosis of apoptotic 
neutrophils is enhanced in macrophages (Frasch et al. 2011).  Briefly, lysophophatidylserine, a 
form of phosphatidylserine produced by NADPH oxidase, signals to macrophages via a G-
protein-coupled receptor, G2A, to enhance efferocytosis.  G2A activation, in turn, enhances 
production of prostaglandin (PG) E2 via a calcium-dependent cytosolic phospholipase 
A2/cyclooxygenase (COX)-mediated mechanism within the macrophage. PGE2 causes enhanced 
activity of Rac1 via adenyl cyclase and protein kinase A activation to increase macrophage 
efferocytosis of apoptotic neutrophils (Frasch et al. 2011). 
 Upon efferocytosis of apoptotic neutrophils, intracellular signaling blocks the release of 
pro-inflammatory mediators while up-regulating anti-inflammatory mediators to cause a change 
in macrophage phenotype from pro-inflammatory to anti-inflammatory (Fadok et al. 1998, 
Huynh et al. 2002).  Specifically, the pro-inflammatory cytokines including IL-1β, IL-8, IL-10, 
GM-CSF, and TNF-α are inhibited while the robust anti-inflammatory cytokine TGF-β1 is 
maximized (Fadok et al. 1998).  Additionally, it has been demonstrated that the cytosolic protein 
S100A9 is involved in suppression of the production of pro-inflammatory mediators nitric oxide 
(NO), hydrogen peroxide, and TNF-α and inhibition of macrophage phagocytic activity (De 
Lorenzo et al. 2010). Alternatively, a subset of macrophages may also undergo cell death by 
autophagy, apoptosis, or oncosis upon efferocytosis of apoptotic neutrophils; however the 
contribution of these processes to the resolution of inflammation is not well-understood (Wang et 
al. 2014). 
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 Phagocytosis of neutrophils by macrophages, in the face of ongoing microbial infection, 
enhances macrophage killing abilities.  Macrophages lack useful antimicrobial substances that 
neutrophils contain including cathelicidins, permeability-increasing protein, lactoferrin, and 
MPO (Silva 2010).  Upon phagocytosis of apoptosing neutrophils, neutrophilic granules, or 
neutrophil apoptotic bodies, macrophages may adopt some portion of neutrophil antimicrobial 
function, thereby improving their destruction of invading microbes (Silva 2011). 
 In conclusion, the interaction of apoptotic neutrophils and macrophages is critical for 
orchestrating a concerted inflammatory response.  In cases where these interactions are out of 
concert, asynchronous inflammation may ensue that could negatively affect the clearance of an 
infection and may contribute to an excessive inflammatory response that is detrimental to the 
body.  Ultimately, the efferocytosis of apoptotic neutrophils shifts the balance of inflammation 
toward resolution and healing. 
1.8 Neutrophil apoptosis associated with inflammatory disease 
It has been well-established in human medicine that ex vivo neutrophil apoptosis is delayed in 
patients experiencing inflammatory diseases ranging from sepsis to inflammatory bowel disease 
(Hofman 2004). For this reason, modulating neutrophil apoptosis has become a focus of 
inflammation researchers, which will be discussed in a later section.  However, before drugs can 
be developed to modulate neutrophil apoptosis, the mechanisms leading to delayed neutrophil 
apoptosis in the face of inflammatory conditions must be explicated, both in the circulating and 
extravasated neutrophil populations. 
The systemic inflammatory response syndrome (SIRS) was a term developed by human 
practitioners to describe a set of clinical parameters they noticed in severely ill patients, 
including alterations in body temperature, heart rate, respiratory rate, white blood cell count, and 
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underlying pathologic mechanism (Bone et al. 1992).  In general, patients must present with at 
least two abnormal parameters to be diagnosed with SIRS.  The term SIRS has also been adopted 
by veterinary practitioners and is defined by the same criteria as for human patients.  One of the 
most common causes of SIRS in humans and animals is sepsis, or in the case of horses, 
endotoxemia.  It has come to the attention of the authors that the terms sepsis and endotoxemia 
are used to describe a patient’s clinical presentation, where supporting diagnostics may be 
lacking.  In these cases, SIRS is probably a more appropriate term.  Nevertheless, it is well-
established that neutrophil apoptosis is invariably delayed in patients experiencing SIRS 
(Fanning et al. 1999, Jimenez et al. 1997, Shang et al. 2007). 
As stated previously, delayed neutrophil apoptosis has two major effects on inflammatory 
processes.  First, an increase in number of neutrophils initiating an inflammatory response can 
cause collateral damage to nearby tissues due to their non-specific methods of killing resulting in 
further recruitment of neutrophils into a site of inflammation.  Second, efferocytosis of apoptotic 
neutrophils by macrophages is a key component from shifting an inflammatory response from 
pro- to anti-inflammatory to initiate the resolution of inflammation.  Taken together, delayed 
neutrophil apoptosis propagates an inflammatory response. 
Delayed neutrophil apoptosis during SIRS is likely multifactorial due to the broad range 
of disease processes that can cause SIRS.  Substances that have been identified in patients with 
SIRS and are also known inhibitors of neutrophil apoptosis include GM-CSF, IL-6, IL-1β, TNF-
α, LPS, complement 5a (C5a), various pathogens, and Fas ligand (Fanning et al. 1999, Guo et al. 
2006, Hofman 2004, Shang et al. 2007).  Specifically, treatment with neutrophils isolated from 
healthy humans with plasma from patients with SIRS resulted in delayed ex vivo neutrophil 
apoptosis that was abrogated by co-incubation with a neutralizing antibody against GM-CSF 
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(Fanning et al. 1999).  Interestingly, this group also demonstrated that neutrophil lifespan in vitro 
could be rescued by treating with recombinant IL-10 in the face of GM-CSF treatment via 
alteration of ROS generation (Fanning et al. 1999). 
There has been a great deal of research evaluating neutrophil apoptosis in patients 
diagnosed with sepsis.  C5a has been identified as playing a key role in delayed neutrophil 
apoptosis in septic rats and human patients through reduction of neutrophil C5a receptor (Guo et 
al. 2006, Unnewehr et al. 2013).  C5a is a strong activator of neutrophils and has been shown to 
be up-regulated in multiple tissues in patients with sepsis (Riedemann et al. 2002).  C5a has 
recently been evaluated as a potential biomarker for prognosticating the outcome of sepsis in 
human patients (Xu et al. 2015).  C5a delays neutrophil apoptosis via the PI3K and MEK/ERK 
signaling pathways, Bad inactivation via phosphorylation, decreased Bim expression, increased 
Bcl-xL expression,  and suppression of procaspase-3 and -9 cleavage into active caspase-3 and -
9, respectively (Perianayagam et al. 2004, Guo et al. 2006).  In addition, treatment of rats with 
anti-C5a antibody during a cecal-ligation-puncture model, abolished sepsis-delayed neutrophil 
apoptosis (Guo et al. 2006).   
Another cause of delayed neutrophil apoptosis in septic patients involves the upregulation 
of Mcl-1 by myeloid nuclear differentiation antigen (MNDA), a protein that has been described 
as a “master regulator of monocytic and granulocytic lineages” (Milot et al. 2012). However, 
Paunel-Görgülü et al. (2009) demonstrated that ex vivo Fas stimulation can overcome Mcl-1-
mediated delayed neutrophil apoptosis in neutrophils isolated from critically ill patients. 
A hallmark of SIRS is alterations of white blood cell count, which can include leukopenia 
or leukocytosis with or without a left shift toward an increase in immature neutrophils.  
Immature neutrophils have a slightly retarded ability to perform normal functions in the face of 
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sepsis or SIRS, such as migration; however, they demonstrated the same capability to prolong 
their lifespan ex vivo following in vivo activation (Drifte et al. 2013).  A trait that is not generally 
evaluated clinically in neutrophils from patients with SIRS is the presence of apoptotic 
neutrophils in circulation; however, a recent study demonstrated that in patients with severe 
trauma or hemorrhagic shock that required emergency surgery, increased neutrophil apoptosis in 
the early post-operative period was associated with a lower incidence of post-operative infection 
and, as expected, the occurrence of neutrophil apoptosis was inversely proportional to the 
severity of SIRS (Morrison et al. 2013).   The authors of this study proposed that neutrophil 
apoptosis likely reduces early tissue injury, which then decreases the susceptibility to subsequent 
infection (Morrison et al. 2013). Taken together, neutrophil apoptosis, or lack thereof, plays a 
significant part in the development of SIRS and its associated sequelae during many disease 
processes. 
1.9 The equine systemic inflammatory response syndrome 
Similar to other species, equine SIRS is defined using clinical parameters with an underlying 
disease process including hyperthermia, tachycardia, tachypnea, leukocytosis or leukopenia with 
a left shift, with only two of these parameters needing to be present to make a diagnosis of SIRS 
(Epstein et al. 2011, Moore and Vandenplas 2014).  Equine practitioners commonly use the 
terms “endotoxemia” and “SIRS” interchangeably, which has been brought to light by a recent 
review by Moore and Vandenplas (2014).  Often time, horses are diagnosed as being 
“endotoxic,” despite the fact that plasma endotoxin is rarely quantified in clinical cases.   Indeed, 
in horses described clinically as being “endotoxemic,” the sensitivity and specificity for the 
limulus amebocyte lysate assay, the assay of choice to identify plasma endotoxin, was only 
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58.4% and 87.5%, respectively (Senior et al. 2011).  Therefore, we propose that the term SIRS 
should be used unless plasma endotoxin has been quantified.  
Additional confusion in terminology involves the use of the term sepsis, which is defined 
by medical dictionaries as a bacterial infection in the tissues or bloodstream. In equine medicine, 
the term sepsis is used rigorously to define cases where bacteria have been cultured; whereas, the 
term sepsis appears to be used interchangeably with SIRS and endotoxemia in human medicine 
and basic research.  Sepsis and endotoxemia both result in the development of SIRS, but SIRS 
can have other etiologies, such as extensive burns or other types of severe trauma independent of 
infection.  A recent study identified activation of the MAPK pathway as a method to differentiate 
SIRS versus sepsis (West et al. 2007); however, we propose that the etiology of the disease needs 
to be considered when defining a disease.  Ultimately, the discrepancy in terminology and 
evaluation of disease processes is important to realize and consider when assessing research on 
SIRS. 
Equine SIRS can be caused by many disease processes; but by far, it is most commonly 
associated with gastrointestinal disease, otherwise known as colic.  In horses admitted to a 
referral hospital for all types of colic, 28% had examination parameters meeting the SIRS criteria 
(Epstein et al. 2011).  Traditionally, SIRS in colic patients is associated with the development of 
endotoxemia due to bacterial translocation after intestinal compromise from intestinal 
strangulation resulting in ischemia and reperfusion injury or from severe intestinal inflammation, 
such as acute colitis (Senior et al. 2011, Moore and Vandenplas 2014).  However, it is likely that 
other factors come into play in the development of SIRS in these cases, one of which could 
include delayed neutrophil apoptosis.  Regardless of the cause, the development of SIRS in 
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horses experiencing colic is associated with a significant increase in morbidity and mortality 
(Epstein et al. 2011, Moore and Vandenplas 2014).   
The end organ affected in severe cases of SIRS that develops to multi-organ dysfunction 
(MODS) in horses tends to be the lamina within the hoof rather than internal organs, such as the 
lung that are affected in other species (Belknap et al. 2009, Suratt and Parsons 2006). 
Interestingly, horses do not develop laminitis from intravenous infusion of LPS alone, but only in 
cases where true gastrointestinal compromise has occurred, such as oligofructose-induced colitis 
(Belknap and Black 2012).  The development of laminitis is one of the major causes of mortality 
in horses experiencing SIRS. 
In conclusion, SIRS from multiple etiologies is a devastating process in the horse and 
requires further investigation into mechanisms that contribute to its development in order to 
develop an effective treatment regimen as currently utilized treatments are often ineffective.  One 
method to investigate the innate immune response associated with the development of equine 
SIRS is to selectively deplete certain leukocytes.  For example, it is possible to deplete 
intravascular macrophages using gadolinium chloride or deplete all types of macrophages using 
liposome-encapsulated bisphosphonates (Parbhakar et al. 2005, Van Rooijen and Sanders 1994).  
Experiments where selected leukocytes are depleted during established inflammatory models 
could contribute significantly to the advancement of knowledge of the innate immune response 
in horses, making the development of targeted therapeutics possible. 
1.10 Equine neutrophil apoptosis 
Neutrophil apoptosis in inflammatory conditions has recently gained attention by equine 
researchers (Brazil et al. 2014, Krista et al. 2013, Niedzwiedz et al. 2014, Turlej et al. 2001, 
Wauters et al. 2012). Brazil et al. (2014) evaluated constitutive equine neutrophil apoptosis in 
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vitro.  As expected, neutrophils became apoptotic over time.  Concurrently, neutrophils 
maintained their ability to generate respiratory burst upon phorbol myristate acetate (PMA), but 
not zymosan-activated serum (ZAS), a form of complement 5a.  Expectedly, ZAS and 
dexamethasone inhibited apoptosis, but LPS unexpectedly increased the occurrence of neutrophil 
apoptosis in a dose-dependent manner. The authors of this study did not attempt to elucidate 
mechanisms of the various treatments for their effect on neutrophil apoptosis. 
 Neutrophil apoptosis has been evaluated in clinical scenarios in the horse.  Wauters et al. 
(2012) demonstrated that neutrophils isolated from septic joints in clinical cases had greater 
viability than neutrophils isolated from healthy joints.  Somewhat unexpectedly, neutrophils 
from septic joints had a higher percentage of apoptotic neutrophils while neutrophils from 
healthy joints had a higher percentage of dead neutrophils.  An important consideration when 
interpreting the results of this study is that the septic joints were infected with multiple types of 
bacteria.  It is known that microbial pathogens have different effects on neutrophil recruitment, 
activation, and lifespan depending on how they have adapted to evade the immune system (Fox 
et al. 2010, Kobayashi et al. 2003).  In addition, it is important to distinguish between viable 
cells, where the cell membrane remains intact, but the stage of cell cycle may be unknown, 
compared to apoptotic cells, where the cell membrane is also intact, but with concomitant 
phosphatidylserine exposure indicating the induction of cell death via apoptotic pathways.  These 
characteristics of cellular lifespan are discussed in the following section for their effect on the 
inflammatory process.  Ideally, neutrophil apoptosis in septic joints should be evaluated using a 
more controlled in vivo model to identify the true pathophysiology of neutrophil lifespan in the 
face of sepsis. 
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 Krista et al. (2013) examined the occurrence of ex vivo neutrophil apoptosis in horses 
undergoing elective orthopedic surgical procedures (little to no systemic inflammatory response) 
compared to horses undergoing abdominal exploratory surgery to correct colic (significant 
systemic inflammatory response).  They further divided the colic surgery group into 
strangulating (high risk of endotoxemia) and non-strangulating (low risk of endotoxemia) 
groups.  There was no difference in the ex vivo occurrence of neutrophil apoptosis between the 
elective orthopedic and colic surgery groups; however, horses with strangulating lesions had 
significantly delayed neutrophil apoptosis compared to horses with non-strangulating lesions.  
Again, mechanisms of apoptosis were not explored in this study.  From the results of this study, 
it is important to recognize that even minor or local inflammation could have a global effect on 
circulating neutrophil lifespan. 
 Lastly, Niedzwiedz et al. (2014) evaluated percentages of apoptotic neutrophils in 
bronchoalveolar lavage fluid (BALF) from healthy horses compared to horses afflicted with 
recurrent airway obstruction (RAO).  RAO horses had reduced amounts of apoptotic neutrophils 
compared to healthy horses.  This is an expected finding based on the fact that horses with RAO 
have inflamed airways with increased neutrophil concentrations that would likely result in 
neutrophil activation and prolongation of neutrophil lifespan. Additionally, GM-CSF 
concentrations are increased in BALF from horses with RAO, which would further delay local 
neutrophil apoptosis (Turlej et al. 2001).  
 Taken together, there is paucity of data on the occurrence of neutrophil apoptosis and 
associated mechanisms in equine inflammatory diseases.  Considering the role of neutrophils in 
inflammatory diseases and the impact of many inflammatory diseases on the horse, it is critical 
to undertake studies to explore the biology of neutrophil apoptosis. Data generated from such 
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studies could also lead to the development of the horse as model for studying neutrophil biology 
as horses are subject to many of the same inflammatory responses as humans and can provide a 
large number of cells for experiments. 
1.11 The induction of neutrophil apoptosis as a future therapeutic target 
Many acute inflammatory diseases are characterized by neutrophil infiltration, particularly those 
involving extracellular pathogens.  One reason that neutrophils are so effective at neutralizing 
pathogens is due to their shear increase in number that allows them to overwhelm the pathogen.  
However, within the process of neutralizing a pathogen, neutrophils cause collateral damage to 
tissues through the release of their cytotoxic granules.  So while they may effectively neutralize 
pathogens, they also potentiate an inflammatory response through damage to neighboring cells 
that then send out danger signals to recruit additional inflammatory cells.  Additionally, in the 
face of neutrophil activation and accumulation, the prolongation of neutrophil lifespan has a 
significant effect on the overall prolongation of the inflammatory response due to inhibition of 
macrophage polarization from a pro- to anti-inflammatory phenotype.  Therefore, the modulation 
of neutrophil apoptosis is an attractive alternative to reducing inflammation in neutrophil-driven 
inflammatory processes, such as sepsis and SIRS. Modulation of neutrophil apoptosis to reduce 
inflammation can potentially be mediated through two separate mechanisms.  One mechanism 
would involve the induction of neutrophil apoptosis at the specific site(s) of inflammation.  A 
second mechanism would be to introduce apoptotic neutrophils into the site of inflammation to 
influence macrophage polarization and, potentially, neutrophil lifespan. 
Within the context of inducing neutrophil death to stimulate an anti-inflammatory 
response, it is important to differentiate apoptosis from necrosis.  Necrosis is characterized as a 
passive, accidental death from environmental perturbations that disrupt tissue homeostasis, while 
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apoptosis is characterized as an active, purposeful death that is beneficial to tissue homeostasis 
(Fink and Cookson 2005). The induction of neutrophil death by necrosis is associated with the 
propagation of inflammation primarily through the lack of membrane integrity causing the 
release of cytotoxic contents; whereas, the induction of neutrophil death by apoptosis is 
associated with the reduction of inflammation through maintenance of membrane integrity and 
subsequent macrophage efferocytosis.   
 The timing of inducing neutrophil apoptosis as part of a therapeutic regimen must be 
developed in order to allow enough time for neutrophils to neutralize the pathogen, but before 
they have accumulated to such a degree as to generate an inappropriate or excessive 
inflammatory response.  It is well-documented that neutropenia, both congenital and iatrogenic, 
leads to increased risk for bacterial and fungal infections (Geering and Simon 2011).  Therefore, 
it is critical that neutrophils are available in the immediate inflammatory period to do their 
intended duties, while later on it may be advantageous to induce apoptosis as a method to 
promote the resolution of inflammation. 
 The induction of neutrophil apoptosis has been initiated using various pharmacologic 
agents that have been used with success in vitro and, to a lesser extent, in vivo in laboratory 
animal models (Duffin et al. 2010, Hallet et al. 2008).  The ideal pharmacologic agent should 
alter a pathway involved in initiating neutrophil apoptosis without causing neutrophil necrosis or 
affecting non-target cells.  As discussed earlier in this review, neutrophil apoptosis is a complex 
process that may utilize multiple pathways to promote or delay apoptosis, including NF-κB, 
MAPK, and PI3K, that ultimately regulate the Bcl2 family of proteins (Hallet et al. 2008). 
Indeed, inhibitors of these pathways have been evaluated, at least in vitro, for their ability to 
modulate neutrophil apoptosis (Hallet et al. 2008).  Thus far, only modulation of NF-κB and the 
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Bcl2 family of proteins have demonstrated promising results in in vivo rodent models of 
inflammation. 
 A physiological inhibitor of NF-κB has been identified as prostaglandin (PG)D2 and its 
metabolite PGJ2 (Hallet et al. 2008, Lawrence et al. 2002). These metabolites of the arachidonic 
acid pathway have been shown to inhibit NF-κB activation and induce caspase-dependent 
apoptosis in neutrophils in vitro (Ward et al. 2004).  Additionally, pre-treatment with PGJ2 
reduced LPS-induced acute lung injury in a rat model (Liu et al. 2014) and post-treatment with 
PGJ2 dramatically improved survival and reduced neutrophil infiltration into tissues in an 
endotoxic shock mouse model (Kaplan et al. 2005).  Products of the arachidonic acid pathway, 
specifically those produced by cyclooxygenases (COX), have been historic targets of drugs 
designed to reduce inflammation, namely corticosteroids, such as dexamethasone, and non-
steroidal anti-inflammatory drugs (NSAIDs).  Indeed, both classes of drugs are commonly used 
to treat inflammatory conditions in veterinary patients.  However, a well-known consequence of 
altering COX function in order to reduce inflammatory metabolites, such as PGE2, is 
interference with production of anti-inflammatory metabolites, including PGD2.  This highlights 
the need to develop more targeted therapeutics in order to circumvent unintentional side effects 
of currently used drugs. 
 Related products of arachidonic metabolism produced through the lipoxygenase (LOX) 
arm of the pathway, called lipoxins (LX), have also been identified as potent anti-inflammatory 
mediators, in part through their ability to modulate neutrophil apoptosis and promote 
macrophage efferocytosis (Hallet et al. 2008, Lawrence et al. 2002).  Specifically, aspirin-
triggered lipoxins (ATL) induce neutrophil apoptosis via activation of Annexin-1, which 
concurrently enhances macrophage efferocytosis to promote the resolution of inflammation 
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(Hallet et al. 2008).  Treatment with aspirin increased concentrations of ATL, which in turn 
reduced platelet-neutrophil aggregation and lung injury in a mouse model of LPS-induced lung 
injury (Ortiz-Muñoz et al. 2014).  
 Perhaps the most promising substance being evaluated for modulation of neutrophil 
apoptosis is R-roscovitine, a cyclin-dependent kinase (CDK).  R-roscovitine has been historically 
investigated as a chemotherapeutic drug in treating cancer and is currently undergoing human 
clinical trials for this purpose.  However, in multiple in vitro studies R-roscovitine induced 
neutrophil apoptosis by down-regulating the anti-apoptotic member of the Bcl2 family Mcl-1, 
even being able to override delayed neutrophil apoptosis caused by GM-CSF and LPS (Gautam 
et al. 2013, Leitch et al. 2010, Rossi et al. 2006).  R-roscovitine has been further evaluated in 
rodent models with promising results by enhancing the resolution of established inflammation 
through the promotion of neutrophil apoptosis (Rossi et al. 2006, Koedel et al. 2009). 
 The second mechanism by which disease process may be modulated by neutrophil 
apoptosis involves the administration of apoptotic neutrophils as a therapy in itself.  The ability 
of apoptotic neutrophils to polarize macrophage phenotype from pro-inflammatory to anti-
inflammatory has been discussed above, and so it follows that investigators have exploited this 
effect to promote the resolution of inflammation in various rodent models (Miles et al. 2009, Ren 
et al. 2008).  Miles et al. (2009) discovered that apoptotic and necrotic neutrophils released α–
defensins from their azurophilic granules, which, in addition to being antibacterial, reduce 
production of pro-inflammatory cytokines and NO from macrophages.  Intra-peritoneal injection 
of necrotic neutrophils containing α-defensins, but not whole apoptotic neutrophils, reduced 
inflammatory cell influx in a mouse thioglycolate model of peritonitis. (Miles et al. 2009).  
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In a study by Ren et al. (2008), the administration of apoptotic neutrophils up to 24 h 
after inducing endotoxic shock in mice reduced circulating pro-inflammatory cytokines, 
neutrophil infiltration in target organs, and serum LPS concentration.  The positive effects of 
administering apoptotic neutrophils in this model are likely multimodal due to non-functional 
apoptotic neutrophils binding and neutralizing LPS and the efferocytosis of apoptotic neutrophils 
driving macrophages toward an anti-inflammatory phenotype.  Esmann et al. (2010) 
demonstrated that neutrophils themselves phagocytose apoptotic neutrophils in vitro leading to 
an inhibition of pro-inflammatory neutrophil functions, such as respiratory burst.  Taken 
together, the administration of apoptotic neutrophils could serve as a simple, yet useful treatment 
modality in treating neutrophilic inflammatory diseases. 
In conclusion, the modulation of neutrophil lifespan as a therapeutic target is in its 
infancy of investigation.  In the future, targeted modulation of an inflammatory response will 
hopefully comprise targeted therapeutic regimens, moving away from the currently used 
nonspecific and generally ineffective methods to reduce severe, life-threatening inflammation. 
 1.12 Summary 
Despite having a relatively short lifespan compared to other leukocytes, the ability of neutrophils 
to alter their lifespan to suit the situation at hand is unique and involves a complex process 
involving multiple intracellular signaling pathways.  Within the scope of an inflammatory 
response, the ability to modulate neutrophil lifespan is an attractive option to better coordinate an 
acute inflammatory response and promote the resolution of inflammation as required. 
 Neutrophil apoptosis has received limited attention by equine researchers; however, the 
horse could serve as an ideal model to study neutrophil lifespan in inflammatory conditions.  The 
following chapters of this thesis form the groundwork for confirming that equine neutrophil 
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lifespan is prolonged in various inflammatory scenarios with the goal of providing a place from 
which further detail of the mechanisms of inflammation-delayed neutrophil may be elucidated 
and then manipulated as part of a multimodal therapeutic regimen for the treatment of 
inflammatory conditions. 
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CHAPTER 2: HYPOTHESES AND OBJECTIVES 
2.1 Hypotheses 
1. Lipopolysaccharide will delay equine neutrophil apoptosis in vitro via down-regulation of 
the intrinsic pathway of apoptosis. 
2. Ex vivo equine neutrophil apoptosis will be delayed following intestinal ischemia and 
reperfusion. 
3. Treatment with parenteral gadolinium chloride to deplete pulmonary intravascular 
macrophages will modulate inflammation associated with intestinal ischemia and 
reperfusion in horses.  
4. Ex vivo equine neutrophil apoptosis will be delayed following the induction of colitis 
with oligofructose overdose. 
5. Treatment with apoptotic equine neutrophils in vitro will rescue LPS- and systemic 
inflammation-delayed neutrophil apoptosis. 
2.2 Objectives 
1. Determine if Escherichia coli lipopolysaccharide delays equine neutrophil apoptosis in 
vitro in a dose-dependent manner.  
2. Investigate mechanisms by which lipopolysaccharide delays equine neutrophil apoptosis 
in vitro. 
3. Determine if ex vivo neutrophil apoptosis is delayed following intestinal ischemia and 
reperfusion. 
4. Determine if depletion of pulmonary intravascular macrophages affects systemic 
inflammation and ex vivo neutrophil apoptosis during an equine intestinal ischemia and 
reperfusion model 
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5. Determine if ex vivo neutrophil apoptosis is delayed following the induction of colitis 
with oligofructose overdose. 
6. Determine if co-incubation of apoptotic neutrophils with freshly isolated neutrophils will 
affect the occurrence of apoptosis in vitro and rescue lipopolysaccharide- and systemic 
inflammation-delayed apoptosis in vitro. 
2.3 Rationale 
Neutrophils are one of the primary cells involved in mounting an acute inflammatory response; 
however, their non-specific methods of neutralizing threats may propagate an overzealous 
inflammatory response, often to the detriment of the body.  It has been shown in humans and 
laboratory animals that neutrophil lifespan is prolonged during inflammatory conditions through 
alteration of apoptotic pathways.  The prolongation of neutrophil lifespan delays the resolution of 
inflammation and may contribute to a prolonged, counter-productive, inflammatory state.   
Therefore, the modulation of neutrophil lifespan has come under investigation as a tool to control 
inflammatory conditions.   
Neutrophil lifespan in inflammatory conditions has received limited attention by equine 
researchers, despite the propensity for horses to develop inappropriate inflammatory responses 
resuling in increased morbidity and mortality.  Lipopolysaccharide entering the bloodstream 
(endotoxemia) is one of the most significant contributors to the development of an inappropriate 
inflammatory response in horses.  The most common cause of equine endotoxemia is from 
gastrointestinal barrier compromise due to infectious or non-infectious intestinal inflammation.  
The focus of the work presented herein is to confirm that equine neutrophils experience 
prolongation of lifespan in the face of inflammatory conditions, specifically those associated 
with endotoxin, and to examine the mechanisms of such an alteration of their lifespan.    
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CHAPTER 3: LIPOPOLYSACCHARIDE DELAYS EQUINE 
NEUTROPHIL APOPTOSIS IN VITRO 
 
3.1 Abstract  
Horses are particularly susceptible to lipopolysaccharide (LPS) endotoxin, generating a robust 
systemic inflammatory response resulting in serious, often life threatening, consequences.  
Delayed neutrophil apoptosis has been implicated, in part, as a contributing factor to the 
development of an inappropriate systemic inflammatory response to LPS in other species, but 
has not been well-studied in horses.  Our objective was to evaluate equine neutrophil apoptosis in 
response to LPS treatment in vitro.  Neutrophil apoptosis was assessed with cytology; Annexin V 
and propidium iodide staining quantified with flow cytometry; caspase-3, -8, and -9 activities; 
and western blotting for NF-κB and A1 proteins in neutrophil lysates.  In vitro treatment with 
LPS resulted in delayed apoptosis after 12 and 24 h incubation in neutrophils isolated from 44 
horses on 79 occasions (12 h: P = 0.008, 24 h: p < 0.001). There was a significant correlation 
between increasing LPS dose and decreasing occurrence of apoptosis after 24 h incubation (r = -
0.67, P < 0.0001). Caspase-9 activity was significantly reduced in LPS-treated neutrophils after 
12 h incubation (P = 0.006).  Treatment with an inhibitor of toll-like receptor 4 (TLR4) and 
inducers of apoptosis rescued LPS-delayed apoptosis.  We conclude that in vitro LPS treatment 
delays equine neutrophil apoptosis for up to 24 h in a dose-dependent manner, and the delay is 
dependent upon TLR4 signaling and alteration of the intrinsic pathway of apoptosis. 
 
 
 
This work has been accepted for presentation at the American College of Veterinary Surgeon 
Surgical Summit.  Nashville, TN, USA.  October 22-24, 2015.   
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3.2 Introduction 
Horses are extremely sensitive to endotoxin in the blood, generating a robust systemic 
inflammatory response to as little as 20 ng/kg of lipopolysaccharide (LPS) endotoxin 
administered systemically (Moore and Vandenplas 2014, Tadros et al 2013).  Horses may 
become endotoxemic from various disease processes, the most common being from lesions 
affecting the gastrointestinal tract including colitis and strangulating intestinal lesions (Moore 
and Vandenplas 2014, Senior et al 2011).  Endotoxemia results from the compromise of the 
intestinal epithelial barrier and subsequent bacterial translocation, ultimately leading to a 
systemic inflammatory response (Moore and Vandenplas 2014, Senior et al 2011, Werners et al 
2005).  Neutrophils are important for the propagation of an inappropriate systemic inflammatory 
response to endotoxin because of their non-specific methods of antigen neutralization, often 
leading to collateral damage to nearby cells and tissues (Werners et al 2005).    
There are two classically described pathways by which a cell may undergo apoptosis.  
The extrinsic pathway involves activation of cell membrane receptors by specific ligands, such 
as tumor necrosis alpha (TNF-α), followed by activation of a cascade of intracellular proteases, 
called caspases, that initiate apoptosis (Fox et al. 2010).  The intrinsic pathway involves a 
shifting of a balance of the B cell lymphoma 2 (Bcl2) family of proteins that maintain 
mitochondrial membrane potential.  An intracellular signal, such as cell stress, activates various 
intracellular signaling pathways, such as mitogen-activated protein kinases (MAPK), that 
ultimately change the balance of the Bcl2 family through changes in specific protein production 
to pro-life or pro-death depending on the situation at hand (Fox et al. 2010). 
 Although not specifically studied in the horse, in other species it is understood that 
neutrophils have a relatively short circulatory lifespan (6-8 h half-life in circulation), which ends 
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with the induction of apoptosis via the intrinsic pathway of apoptosis (Edwards et al 2004, Jia et 
al 2008, Tak et al 2013).   The abbreviated life span of neutrophils may be a mechanism by 
which the body removes a potentially activated cell population, thereby having a role in anti-
inflammatory processes (Savill et al 2002).  Indeed, the phagocytosis of apoptotic neutrophils by 
macrophages results in release of anti-inflammatory cytokines such as TGF-β and the inhibition 
of pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-8, and tumor necrosis factor 
(TNF)-α (Fadok et al 1998, Huynh et al 2002, Lucas et al 2003).  In addition, neutrophil 
apoptosis is the primary signal for their removal from the blood by professional phagocytic cells, 
especially macrophages, located in the spleen, liver, and bone marrow (Hofman 2004, Tak et al 
2013).   
Delayed neutrophil apoptosis has been implicated in the development of an inappropriate 
systemic inflammatory response to endotoxin and the prevention of the resolution of 
inflammation (Hofman 2004, Milot et al 2012, O’Brien and Kirby 2008, Serhan and Savill 
2005).  It is well-accepted that bacterial LPS or sepsis delays neutrophil apoptosis in laboratory 
mammals and humans in vitro and in vivo (Colotta et al 1992, Jia et al 2008, Milot et al 2012, 
Sano et al 2005, Sweeny et al 1998, Yamamoto et al 1993). The proposed mechanism of delayed 
neutrophil apoptosis in response to LPS is influenced by activation of the nuclear factor kappa B 
(NF-κB) and phosphoinositide 3-kinase (PI3) pathways via toll-like receptor (TLR) 4 signaling 
leading to an increase in anti-apoptotic proteins, such as B-cell lymphoma (Bcl)-2, myeloid 
leukemia cell (Mcl)-1, and A1, that down-regulate the intrinsic pathway of apoptosis (Edwards, 
et al., 2004, François et al., 2005).   
To the authors’ knowledge, there is only a single study in the literature evaluating the 
effect of LPS treatment on equine neutrophil lifespan in vitro (Brazil et al. 2014).  This group 
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demonstrated an increase in neutrophil apoptosis upon LPS treatment, which is in direct contrast 
to results from all other species.  Because horses are highly susceptible to the effects of 
endotoxin, further evaluation of the effect of LPS on neutrophil lifespan was needed.  The 
objective of this study was to investigate the effect of LPS treatment on the occurrence of 
apoptosis in equine neutrophils in vitro.  We hypothesized that LPS would delay apoptosis in 
equine neutrophils in a dose-dependent manner via down-regulation of the intrinsic pathway of 
apoptosis.  
3.3 Materials and Methods 
3.3.1 Animals 
Healthy adult horses were used for all experiments.  All procedures and experimental protocols 
were approved by the University of Saskatchewan Committee on Animal Care and Supply and 
the University of Saskatchewan Animal Research Ethics Board. 
3.3.2 Neutrophil isolation 
Neutrophils were isolated using a previously reported protocol with minor modification (Cook et 
al. 2009).  Blood was collected aseptically from a jugular vein into vacuum tubes containing 
ethylenediaminetetraacetic acid (EDTA, Vacutainer™, BD, Mississauga, ON, Canada).  Isolation 
was performed at room temperature (20-22°C) immediately after blood collection.  The blood 
was allowed to separate into plasma and red cell fractions for 30-45 min at room temperature.  
Plasma was layered onto 10 ml Ficoll-Paque™ Plus (GE Healthcare, Mississauga, ON, Canada) 
and centrifuged for 30 min at 400 x g.  The subsequent pellet, containing erythrocytes and 
granulocytes, was retained after aspirating the supernatant and washed with Hank’s Buffered Salt 
Solution (HBSS) without phenol, magnesium, or calcium for 10 min at 200 x g.  Erythrocytes 
were lysed with 2 ml sterile distilled water with pH of 7.4 for 25 s and restored to normotonicity 
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with an equal volume of hypertonic (2x) HBSS.  Cells were washed 3 times with HBSS at 200 x 
g for 10 min, suspended in culture medium (Roswell Park Memorial Institute (RPMI) 1640 
medium containing 10% fetal bovine serum, 2 mM L-glutamine, 100 IU/ml penicillin, 50 μg/ml 
streptomycin, and 25 mM Hepes, Lonza BioWhittaker®, VWR, Edmonton, AB), assessed for 
viability using Trypan blue staining, and counted with a hemocytometer.  Cell purity was 
determined on cytology preparations made with a cytocentrifuge  (Shandon Cytospin 4, Thermo 
Scientific, Waltham, MA, USA) at 1000 rpm for 4 min with medium acceleration and stained 
with a modified Giemsa stain (Hemacolor®, EMD chemical, Gibbstown, NJ). Experiments 
proceeded if viability was greater than 98% and purity was greater than 90%. 
3.3.3 Neutrophil culture conditions 
Neutrophils were suspended in culture medium in plastic 24-well cell culture plates at a 
concentration of 2 x 106 cells/ml.  Cells were left untreated or were treated with various 
concentrations of LPS (Escherichia coli 055:B5, Sigma-Aldrich Canada, Oakville, ON, Canada). 
For mechanistic experiments, neutrophils were cultured with LPS and inducers of apoptosis 
gambogic acid (GA, 2 μg/ml, apoptosis inducer via inhibition of anti-apoptotic Bcl2 proteins, 
Enzo, Farmingdale, NY, USA) or staurosporine (Stauro, 2 μM, apoptosis inducer via pan-
caspase activation, Biovision, Milpitas, CA, USA); with TLR4 inhibitor CLI-095 (1 μg/ml, 
Invivogen, San Diego, CA, USA); or with the dissolving agent dimethyl sulfoxide (1 μl/ml 
DMSO, Sigma-Aldrich Canada, Oakville, ON, Canada).  For all experiments, cells were 
incubated at 37°C in 5% CO2 for various times depending on experiment.  Prior to performing 
apoptosis assays, neutrophils were taken out of culture, pelleted, and washed twice with HBSS at 
400 x g for 8 min.   
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3.3.4 Apoptosis assays 
3.3.4.1 Cytology 
Cytology preparations were prepared as for assessment of sample purity after neutrophil 
isolation.  Neutrophil nuclear morphology was evaluated by the first author, who was blinded to 
treatment, with light microscopy at 100X magnification.  Neutrophils were classified as 
apoptotic if they were karyorrhectic or pyknotic (Savill et al., 1989). Five hundred neutrophils 
were counted in multiple random fields to provide a percentage of apoptotic neutrophils out of 
normal neutrophils. 
3.3.4.2 Flow cytometry 
Neutrophils were stained with CF™488-conjugated Annexin V (AV) and propidium iodide (PI) 
per manufacturer’s instructions (CF™488A-Annexin V and PI Apoptosis Assay Kit, Biotium, 
Hayward, CA, USA).  Staining controls included unstained untreated cells, untreated cells 
stained with AV only, and untreated stained with PI only. A flow cytometer (CyFlow®, Partec, 
Swedesboro, NJ, USA) was used to quantify negatively stained (live cells), AV positively 
stained (apoptotic cells), or AV and PI positively stained (dead) cells. Flow cytometry data were 
analyzed with commercial software (FlowMax Software © Version 2.6, Quantum Analysis 
GmbH, Münster, Germany).  The gated population was determined with unstained cells based on 
size (forward scatter) and granularity (side scatter).  Quadrants to set threshold of fluorescence 
intensity for both Annexin V and PI were determined using untreated cells stained with only AV 
or PI. Data were acquired on at least 10,000 gated events.   
3.3.4.3 Caspase activity assay 
Caspase-3, -8, and -9 activities were indirectly measured using a commercially available kit per 
manufacturer’s instructions (Caspase-3, -8, or -9 Colorimetric Assay Kit, Biovision, Milpitas, 
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CA, USA).  Caspase-3 activity was measured to determine overall apoptotic activity, caspase-8 
activity was measured to assess the contribution of the extrinsic pathway, and caspase-9 activity 
was measured to assess the contribution of the intrinsic pathway on the occurrence of neutrophil 
apoptosis.  Neutrophils were lysed using the manufacturer’s lysis buffer following removal from 
culture and washing as described above. Cell lysates were stored at -80°C until processing.  
Upon thawing, protein concentration in cell lysates was quantified using a commercial kit (DC™ 
Protein Assay, Bio-Rad Laboratories, Mississauga, ON, Canada). Cell lysates were incubated 
with a manufacturer’s reaction buffer containing dithiothreitol (DTT) and each caspase’s 
substrate: DEVD-pNA (caspase-3), IETD-pNA (caspase-8), or LEHD-pNA (caspase-9) in 96-
well plates for 2 h at 37°C. Immediately after incubation, free pNA was quantified by measuring 
absorbance at 405 nm in a microtiter plate reader. Levels of free pNA were corrected for protein 
concentration in cell lysates.  
3.3.4.4 Immunoblotting for inflammatory and apoptotic proteins 
Western blots were performed on neutrophils lysed with radioimmunoprecipitation assay (RIPA) 
buffer (Sigma-Aldrich Canada, Oakville, ON, Canada) containing protease inhibitor (cOmplete 
protease inhibitor cocktail tablets, Roche, Mississauga, ON, Canada).  Protein concentrations in 
cell lysates were quantified using the DC™ Protein Assay (Bio-Rad Laboratories, Mississauga, 
ON, Canada) and cell lysates were diluted to a standard protein concentration using RIPA buffer.  
Lysates were diluted and boiled with Laemmli sample buffer (Bio-Rad Laboratories, 
Mississauga, ON, Canada) containing 10% 2-mercaptoethanol (Sigma-Aldrich Canada, Oakville, 
ON, Canada) at 95°C for 5 min, run on a 12% SDS-PAGE gel, transferred to a low-fluorescent 
polyvinylidene fluoride (PVDF) membrane (Amersham Hybond™-LFP, GE Healthcare, 
Mississauga, ON, Canada), and immunoblotted with antibodies against anti-apoptotic protein A1 
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(Santa Cruz Biotechnologies, Dallas, TX, USA), nuclear factor kappa B (NFκB, Abcam Inc, 
Toronto, ON, Canada), and housekeeping protein beta-actin (Abcam Inc, Toronto, ON, Canada).  
Species- and immunoglobulin-appropriate fluorescent-labeled secondary antibodies were used to 
label primary antibodies (Santa Cruz Biotechnologies, Dallas, TX, USA).  Blots were developed 
using a fluorescent membrane reader (Typhoon 9400, GE Healthcare, Mississauga, ON, 
Canada).  Densitometry was performed by comparing relative fluorescence of protein of interest 
to the housekeeping protein using imaging software (ImageJ, National Institutes of Health, 
USA). 
3.3.5 Statistical analysis 
Data were analyzed with a commercial software package (Graphpad Prism, Graphpad Software, 
Inc. La Jolla, CA, USA). For all comparisons, a P-value of < 0.05 was considered significant.  A 
Shapiro-Wilk test of normality was performed on all dependent variables.  A Spearman’s rank 
correlation was performed to assess correlation of flow cytometry data with light microscopy.  
Linear regression and a Spearman’s rank correlation were used to assess the effect of LPS 
concentration on the occurrence of neutrophil apoptosis.  For normal data, multiple comparisons 
among continuous variable were assessed with one-way ANOVA with Bonferroni’s post-hoc 
analysis and comparisons between two continuous variables were assessed with a Student’s t-
test.  Data are reported as mean with standard deviation (SD).  For non-normal data, multiple 
comparisons among continuous variables were assessed with a Kruskal-Wallis rank test with a 
Dunn’s multiple comparisons test and comparisons between two continuous variables were 
assessed with a Mann-Whitney U test.  Data are represented by median and range. 
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3.4 Results 
3.4.1 LPS treatment delays equine neutrophil apoptosis in vitro in a dose-dependent manner 
For determination of dose dependency of the effect of LPS on apoptosis, neutrophils were 
isolated for 3 separate experiments using 3 horses.  Neutrophils were treated with 0.001 μg/ml, 
0.01 μg/ml, 0.1 μg/ml, 1 μg/ml, or 10 μg/ml LPS or left untreated and cultured for 24 h.  
Neutrophil apoptosis, as determined by Annexin V and PI staining, was reduced by LPS 
treatment in a dose-dependent manner where increasing dose of LPS was significantly correlated 
with reduced apoptosis (r = -0.97, P = 0.003, Figure 3.1).  Treatment with LPS concentrations of 
0.1, 1, and 10 μg/ml significantly reduced apoptosis in neutrophils after 24 h in culture compared 
to untreated cells (0.01 μg/ml LPS: P = 0.037, 0.1 μg/ml LPS: P = 0.003, 1 μg/ml LPS: P < 
0.001, 10 μg/ml LPS: P < 0.001, Figure 3.1). 
Neutrophils were isolated from 44 horses on 79 occasions.  Following isolation, 
neutrophil viability was greater than 99% and purity averaged 93.5% (SD: 2.3%) with 
eosinophils serving as the primary contaminating cell type.  Neutrophils were cultured for 12 or 
24 h with or without 1 μg/ml LPS.  There was a significant reduction in the occurrence of 
apoptosis as measured by Annexin V positive and PI negative staining at both time points for 
cells treated with LPS compared to untreated cells (12 h: P = 0.008, 24 h: P < 0.001, Figure 3.2).  
There was no difference in percentages of live cells (Annexin V negative and PI negative) or 
dead cells (Annexin V positive and PI positive) after 12 h of culture; but after 24 h, there were 
significantly more live cells with LPS treatment (P < 0.001, Figure 3.2).   
Nuclear morphology was concurrently assessed in neutrophils isolated from 8 horses 
following culture for 12 or 24 h with or without 1 μg/ml LPS.  There was a significant reduction 
in apoptotic neutrophils as measured by altered neutrophil nuclear morphology at both time 
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points. (Figure 3.3, 12 h: P = 0.0008, 24 h: P = 0.0002).  Light microscopy results were highly 
correlated with flow cytometry results at 12 h (r = 0.66, P = 0.006) and 24 h (r = 0.90, P < 
0.001).  
 3.4.2 LPS treatment modifies the intrinsic pathway of equine neutrophil apoptosis via TLR4 
signaling 
Evaluation of caspase activity was used to identify the involvement of the intrinsic and extrinsic 
pathways.  Caspase-8 and -9, both initiator caspases, were chosen to identify activation of the 
extrinsic and intrinsic pathways, respectively.  Caspase-3 activity was used to identify overall 
apoptotic activity as it is an effector caspase for both the extrinsic and intrinsic pathways. When 
caspase activity was compared between untreated and LPS-treated cells isolated from 16 horses 
after 12 h of incubation, there was no difference in caspase-3 or caspase-8 activity between 
untreated and LPS-treated cells, but there was a significant reduction in caspase-9 in LPS-treated 
compared untreated cells (P = 0.012, Figure 3.4).  After 12 h of incubation, treatment with LPS 
resulted in increased total NF-κB and decreased A1protein expression, although the difference 
was not statistically significant (NF-κB: P = 0.24, A1: P = 0.18, Figure 3.5). 
Co-incubation of neutrophils with CLI-095, a chemical that blocks the intracellular 
domain of TLR4, and LPS for 24 h reduced LPS-delayed neutrophils apoptosis (1 experiment in 
7 horses, P < 0.05, Figure 3.6).   
In neutrophils isolated from 6 horses and cultured for 12 h with pan-caspase activator 
staurosporine or inhibitor of the anti-apoptotic Bcl2 proteins gambogic acid and LPS increased 
apoptosis compared to LPS treated cells, as measured by Annexin V and PI staining and flow 
cytometric quantification (P < 0.05, Figure 3.7). 
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Figure 3.1 Apoptosis is reduced in equine neutrophils by in vitro LPS treatment in a dose-
dependent manner. Data pointes represent the mean and standard deviation from 3 separate 
experiments in 3 horses. Data were analyzed with linear regression.  P-values represent 
difference in the occurrence of apoptosis from untreated neutrophils. 
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Figure 3.2 LPS delays equine neutrophil apoptosis in vitro. Incubation of equine neutrophils for 
12 or 24 h with or without 1 μg/ml LPS. a) Representative results for flow cytometric 
quantification of Annexin V and PI staining. Live neutrophils are Annexin V and PI negative 
(Q3), apoptotic neutrophils are Annexin V positive and PI negative (Q4), and dead neutrophils 
are Annexin V positive and PI positive (Q2). b) Graphic representation of flow cytometric 
quantification of neutrophil apoptosis.  Data represents mean ± SD from 79 neutrophil isolations 
from 44 horses.  Comparison between untreated and LPS treated cells for each neutrophil 
outcome was assessed with a Student’s t-test. 
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Figure 3.3 a) Representative cytology preparations evaluating neutrophil nuclear morphology 
after 12 and 24 h incubation.  Arrows indicate apoptotic neutrophils. b) Graphic representation of 
cytology data. Bar represents median and data represents 1 experiment on neutrophils isolated 
from 8 horses.  Comparisons between treatments for each time point were assessed with a Mann-
Whitney U test. 
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Figure 3.4 Caspase-9, but not Caspase-3 or Caspase-8, activity was reduced in equine neutrophils 
treated with LPS (1 μg/ml) for 12 h. Bar represents median. Data represents 1 experiment on 
neutrophils isolated from 16 horses.  Comparison between treatments was analyzed with a Mann-
Whitney U test. 
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Figure 3.5 There was no difference in NF-κB and A1 protein expression in equine neutrophils 
treated with LPS for 12 h in culture compared to untreated cells. a) Representative immunoblots 
from equine neutrophil lysates after 12 h of incubation. b) Relative expression of NF-κB and A1 
based on densitometry.  Data are corrected with density of the corresponding β-actin band. Data 
represent 1 experiment in 6 horses. Bar represents the median. Data were analyzed with the 
Mann-Whitney U test. 
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Figure 3.6 LPS-delayed neutrophil apoptosis is dependent upon TLR4 signaling.  Treatment with 
CLI-095 inhibited LPS-delayed neutrophil apoptosis during 24 h in culture. Bar represents 
median. Data represents 1 experiment on neutrophils isolated from 7 horses.  Data were analyzed 
with a Kruskal-Wallis rank test with a Dunn’s multiple comparisons test. Difference in letters 
denotes significant difference among groups (P < 0.05).   
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Figure 3.7 Inducers of apoptosis effectively rescued LPS-delayed neutrophil apoptosis.  a) 
Treatment with 2 μg/ml gambogic acid (GA), 2 μg/ml gambogic acid and 1 μg/ml LPS (GA + 
LPS). Data represent 1 experiment in 6 horses. b) Treatment with 2 μM staurosporine (Stauro), 
or 2 μM staurosporine and 1 μg/ml LPS (Stauro + LPS). Data represent 1 experiment in 6 horses. 
Bars represent medians for each treatment. Data were analyzed with a Kruskal-Wallis rank test 
with a Dunn’s multiple comparisons test.  Difference in letters denotes significant difference 
among groups (P < 0.05).   
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3.5 Discussion 
The results of our study support the hypothesis that LPS delays apoptosis in a dose-dependent 
manner in equine neutrophils in vitro.  Though the mechanism by which LPS delays apoptosis in 
equine neutrophils was not fully elucidated, our results suggest that LPS treatment interferes with 
the intrinsic pathway of apoptosis through reduced caspase-9 activity and is dependent on TLR4 
signaling.   
Recently, Brazil et al. (2014) reported that treatment of equine neutrophils with multiple 
types of LPS in vitro promoted neutrophil apoptosis, which is in direct contrast to our results and 
findings in other species, including humans (Colotta et al. 2012, François et al. 2005, Jia et al. 
2008, Milot et al. 2012, Sano et al. 2005, Sweeny et al. 1998, Yamamoto et al. 1993). It must be 
stated that there was substantial inter-horse and, to a lesser extent, inter-experiment variability, in 
the effect of LPS treatment on equine neutrophil apoptosis in our study. Therefore, it is possible 
that a lower number of experimental units (especially biologic units represented by number of 
horses) could lead to the opposite result, such as reported by Brazil et al. who reported results for 
triplicate experiments in 10 horses.  In select horses, we performed up to six replicates of the 
experiment to assess the occurrence of apoptosis after 12 and 24 h of incubation using Annexin 
V and propidium iodide. 
The discrepancy in our results compared to Brazil et al. could be due to the challenges in 
working with neutrophils. Neutrophils are highly reactive cells, so small differences in the health 
status of a horse, neutrophil isolation procedures, contamination, type of LPS, and culture 
conditions could have a profound effect on their short life span in culture (Attalah et al. 2012, 
Freitas et al. 2008, Hannah et al. 1998, Haslett et al. 1985, Sabroe et al., 2002, Tennenberg et al. 
1988, Watson et al. 1992).  Activation, or lack thereof, may have an effect on neutrophil’s 
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responsiveness to LPS leading to differential responses to the in vitro occurrence of apoptosis.  
To the authors’ knowledge, there are no studies that have specifically addressed the occurrence 
of neutrophil apoptosis in vitro after pre-stimulation with an activating substance, such as LPS.  
In this study, neutrophil apoptosis was delayed in a dose-dependent manner, which has 
been previously demonstrated in human neutrophils (Sweeney et al. 1998).  However, the 
concentration of LPS (1 μg/ml) to which neutrophils were exposed to in prolonged culture 
conditions to reliably delay apoptosis in this study would be difficult to achieve in a horse 
systemically.  First, LPS is rapidly removed from the equine blood compartment after 
intravenous infusion (Fessler et al. 1989); and second, if such a concentration was achieved in 
the blood, it would be approaching the lethal dose of LPS for a horse (150-175 μg/kg or ~2 
μg/ml blood volume, Burrows 1981).   However, it is possible that activation of a small 
population of neutrophils by a relatively high concentration of LPS could lead to a global effect 
on neutrophil lifespan in vivo through intercellular signaling via cytokine production and 
mononuclear cell activation.  Further investigation is required to evaluate ex vivo neutrophil 
lifespan following in vivo LPS challenge.  
We further explored the mechanisms of LPS-delayed neutrophil apoptosis. As expected 
based on known pathways of LPS activation, delayed equine neutrophil apoptosis was dependent 
upon TLR4 signaling.  These results support the current mechanism proposed in other species for 
LPS-delayed neutrophil apoptosis (Figure 3.8).  We used a TLR4 inhibitor that is a cyclohexene 
derivative, called CLI-095 or TAK-242.  This substance was first identified for its ability to 
modulate sepsis and later it was found to suppress TLR4 signaling by blocking its intracellular 
domain (Kawamoto et al. 2008).  To our knowledge, CLI-095 has not been used to evaluate 
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neutrophil apoptosis, but it has been used to evaluate other neutrophil signaling pathways 
involving TLR4 (Lefebvre et al. 2011). 
One of the end pathways of neutrophil TLR4 activation involves NF-κB formation to up-
regulate protein transcription; however in our study, the results of western blot analysis for anti-
apoptotic protein A1 and NF-κB are equivocal.  This result is somewhat unexpected based on 
known pathways of LPS-delayed apoptosis in human neutrophils where both NF-κB and A1 
expression have been shown to be elevated (Chuang et al. 1998, François et al. 2005, Figure 3.8).  
NF-κB is considered to be the major regulator of production of the Bcl2 family of proteins, 
which are vital for determining pro-life vs pro-death in neutrophil survival (Fox et al. 2010). For 
example, A1 protein expression is considered to be dependent upon NF-κB translocation, so it is 
difficult to explain the tendency for an opposite level of expression in our results (Vogler 2012).  
However, A1 is an extremely unstable protein with a short half-life of approximately 3 h 
(Moulding et al. 2001).  Therefore, the discrepancy in these results is more likely due to the 
choice of sampling time in the continuum of in vitro neutrophil apoptosis.  The data presented 
for these proteins represents one point in time.  It is possible that if the expression of these 
proteins was evaluated over time, a difference in expression with LPS treatment would become 
evident.  Ideally, more proteins of the Bcl2 family would have been evaluated, however we 
struggled to find antibodies that were compatible with equine proteins of interest.   
The reduction in caspase-9 activity and increased occurrence of apoptosis upon 
concurrent LPS and gambogic acid treatment suggests that the intrinsic pathway is affected by 
LPS treatment as has been previously demonstrated in other species (Edwards et al. 1992, 
François et al. 2005, Figure 3.8).  Caspase-9 is the main initiator caspase for the intrinsic 
pathway of apoptosis.  It has previously been reported that caspase-9 activity was reduced in 
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neutrophils isolated from septic human patients supporting the importance of its role in LPS-
delayed neutrophil apoptosis (Taneja et al. 2004).  However, to the authors’ knowledge, this is 
the first study that has demonstrated reduced caspase-9 activity upon treatment of neutrophils 
with LPS in vitro. In a human melanoma cell line, gambogic acid induces apoptosis through 
regulation of the pro-apoptotic Bcl2 protein Bax and the anti-apoptotic protein Bcl2 (Xu et al. 
2009); although to the authors’ knowledge, there are no studies evaluating the effect of gambogic 
acid treatment on neutrophil apoptosis in vitro.  Further investigation is required to identify the 
effect of gambogic acid on Bcl2 family protein expression in equine neutrophils. 
It is becoming apparent that neutrophil apoptosis or delayed apoptosis occurs via 
alternative pathways in the face of various substances.  For example granulocyte colony-
stimulating factor delays neutrophil apoptosis independently of the Bcl-2 family of proteins by 
inhibiting calcium-dependent cysteine proteases called calpains while stabilizing X-linked 
inhibitor of apoptosis that, in turn, inhibits caspase-3 and -9 in human neutrophils (van Raam et 
al. 2008). It is possible that an alternative method of apoptosis inhibition occurred due to LPS 
treatment in equine neutrophils.  Further experiments need to be performed to further investigate 
apoptosis in equine neutrophils, including the evaluation of additional proteins and signaling 
pathways that might be involved. 
In conclusion, equine neutrophil apoptosis was delayed in vitro after treatment with >1 
μg/ml LPS from Escherichia coli 055:B5 through reduced capase-9 activity, dependent upon 
TLR4 signaling.   Further work is necessary to fully elucidate the mechanisms involved in LPS-
delayed apoptosis in equine neutrophils.  From the results presented here, it is conceivable that 
alteration of the classical intrinsic apoptotic pathway is not the only cause of LPS-delayed 
apoptosis in neutrophils. 
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Figure 3.8.  Proposed mechanism of LPS-delayed apoptosis in equine neutrophils. 
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3.6 Contineo to in vivo models reported in Chapters 4 and 5 
After verifying that treatment with LPS, albeit at a relatively high dose, did in fact delay equine 
neutrophil apoptosis in vitro, the next step was to assess neutrophil apoptosis in equine models 
that are associated with “endotoxemia.”  Chapter 4 contains data on the occurrence of ex vivo 
neutrophil apoptosis associated with intestinal ischemia and reperfusion, a commonly used 
model of intestinal inflammation and a model that has reported measurable concentrations of 
endotoxin in the blood (Moore et al. 1981).  Chapter 5 has data on the occurrence of ex vivo 
neutrophil apoptosis associated with an oligofructose-induced colitis, a model that creates 
significant signs of systemic inflammation that are conventionally attributed to endotoxemia. 
We chose these models of gastrointestinal inflammation over an LPS-infusion model for 
2 reasons.  First, equine LPS-infusion models do not mimic a true clinical scenario as has been 
demonstrated by the fact that horses do not experience laminitis, a complication of clinical cases 
of endotoxemia.  Horses demonstrate a multitude of clinical signs including tachycardia, 
tachypnea, colic, hyperthermia, and neutropenia followed by rebound neutrophilia that are 
consistent with SIRS.  However, all of these signs are transient and horses rapidly recover 
following LPS infusion, which does not mimic the clinical scenario of a horse diagnosed as 
having endotoxemia, most commonly from underlying gastrointestinal disease. 
Second, we were interested in evaluating the role of pulmonary intravascular 
macrophages (PIMs) in systemic inflammation associated with intestinal ischemia and 
reperfusion injury.  PIMs are a unique type of macrophage that are attached intimately to the 
endothelium of the alveolar capillaries.  Similar to Kupffer cell, they are exposed to the entire 
blood volume as it passes through the lung for oxygenation.  Therefore, they may play a 
significant role in modulating an inflammatory response, including neutrophil apoptosis. 
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CHAPTER 4: EQUINE NEUTROPHIL LIFESPAN IS 
PROLONGED IN HORSES EXPERIENCING JEJUNAL 
ISCHEMIA AND REPERFUSION  
4.1 Abstract 
Dysregulation of neutrophil apoptosis may contribute to the development of an excessive 
systemic inflammatory response in horses as in other species, but requires further investigation 
especially because horses are highly sensitive to systemic endotoxemia. The objective of this 
study was to determine the effect of systemic inflammation, using an experimental model of 
intestinal ischemia and reperfusion injury, on ex vivo neutrophil apoptosis in horses. Neutrophils 
were isolated before and after surgery from horses that were randomized to 3 treatment groups:  
sham celiotomy (CEL, n=4), intestinal ischemia and reperfusion (IR, n=6), intestinal ischemia 
and reperfusion with gadolinium chloride treatment to deplete pulmonary intravascular 
macrophages (IRGC, n=6). Neutrophil apoptosis was assessed with Annexin V and propidium 
iodide staining quantified with flow cytometry and caspase-3, -8, and -9 activities in neutrophil 
lysates. All horses experienced a systemic inflammatory response following surgery without 
detectable plasma endotoxin concentrations 2 h following reperfusion (<0.06 EU/ml).  Caspase-3 
activity was reduced in freshly isolated neutrophils from IR horses (P = 0.03). Following 
surgery, neutrophil apoptosis was significantly delayed after 12 or 24 h in culture, except in 
IRGC horses (12 h: CEL: P = 0.03, IR: P = 0.05, IRGC: P =0.2; 24 h: CEL: P = 0.001, IR: P = 
0.004, IRGC: P = 0.3). Caspase-3, -8, and -9 activities were significantly reduced in neutrophils 
isolated after surgery and cultured for 12 h in IR horses, but not IRGC horses (IR caspase-3: P = 
0.002, IR caspase-8: 0.002 P =, IR caspase-9: P = 0.04). Following surgery, ex vivo equine 
neutrophil apoptosis was delayed via down-regulation of caspase activity, which could have 
implications for the development and progression of systemic inflammatory responses.  
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Additionally, PIM depletion may rescue neutrophil apoptosis through the modulation of plasma 
cytokines and reduced down-regulation of caspase activity. 
This work has been presented as a poster at Experimental Biology, Boston, MA, USA, April 1, 
2015 and the American College of Veterinary Surgeon Surgical Summit, Nashville, TN, USA, 
October 22-24, 2015.   
 
4.2 Introduction  
Neutrophils serve as one of the primary effector cells of the innate immune response triggered by 
danger- or pathogen-associated molecular patterns. Upon neutrophil activation with substances, 
such as lipopolysaccharide (LPS), there is a concomitant prolongation of lifespan through 
delayed constitutive apoptosis, although this has not been fully established in horses (Brazil et al. 
2014, Colotta et al. 1992, Lee et al. 1993).  Delayed neutrophil apoptosis has a direct effect on 
the magnitude and duration of the innate immune response as a whole, which may contribute to 
the development of a highly exuberant innate immune response, also known as the systemic 
inflammatory response syndrome (SIRS), in two ways (Fanning et al. 1999, Jimenez et al. 1997, 
Shang et al. 2007).  First, neutrophils are histotoxic due to their non-specific method of 
neutralizing threats through de-granulation, which may result in further inflammation with 
additional neutrophil activation and recruitment (Wright et al. 2010).  Second, the resolution of 
inflammation begins, in large part, with the efferocytosis of apoptotic neutrophils by 
macrophages causing their phenotype to change from an inflammatory M1 phenotype to an anti-
inflammatory M2 phenotype (Fadok et al. 1998, Hofman 2004, Lucas et al. 2003).  Therefore, 
the delay in neutrophil apoptosis slows the onset of macrophage-driven resolution of 
inflammation (McCracken and Allen, 2014). 
One of the most common causes of SIRS in horses is endotoxemia from gastrointestinal 
compromise (Moore and Vandenplas 2014).  In the case of small intestinal strangulation, 
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endotoxin (bacterial LPS) enters the circulation through a compromised intestinal epithelial 
barrier (Moore et al. 1981).  The inflammatory response to endotoxemia in the horse is profound 
and carries increased morbidity and mortality in horses with gastrointestinal disease.  In a recent 
study, horses with strangulating intestinal lesions had delayed ex vivo neutrophil apoptosis 
compared to horses with non-strangulating lesions, however the mechanisms as to why 
neutrophil apoptosis was delayed were not fully explored (Krista et al. 2013). 
Compared to the study on the role of extravascular tissue macrophages in inflammatory 
processes, including delayed neutrophil apoptosis, the biology of pulmonary intravascular 
macrophages (PIMs) has not received the same attention for their contribution to a systemic 
inflammatory response in any species (Ahronson-Raz et al. 2010). Equine PIMs up-regulate their 
expression of toll-like receptors (TLR)2, 4 and 9, and cytokines interleukin (IL)-1β and tumor 
necrosis factor alpha (TNF-α) during intravenous Escherichia coli LPS challenge (Parbhakar et 
al. 2005, Schneberger et al. 2009, Suri et al. 2006); but, parenteral treatment with gadolinium 
chloride (GC), a chemical used to induce apoptosis in PIMs, reduces IL-1β and TNF-α 
expression by PIMs, as well as total lung TLR4 and TLR9 expression, in this model (Parbhakar 
et al. 2005).  Depletion of PIMs reduces migration of neutrophils into the alveoli of horses with 
recurrent airway obstruction (Aharonson-Raz et al. 2012). However, there are no data on the role 
of PIMs in modulating neutrophil apoptosis in SIRS.  
We hypothesized that ex vivo neutrophil apoptosis would be delayed in horses following 
intestinal ischemia and reperfusion (IR) and that treatment with GC would reduce the systemic 
inflammatory effects associated with intestinal IR, including delayed neutrophil apoptosis.  
Therefore, our objective was to evaluate the effect of intestinal inflammation, using a model of 
equine intestinal ischemia and reperfusion (IR) that has previously been shown to cause 
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endotoxemia (Moore et al. 1981), on ex vivo neutrophil apoptosis. In addition, we wanted to 
determine the effect of depleting PIMs using GC on the systemic inflammatory response 
following intestinal IR, including ex vivo neutrophil apoptosis.   
4.3 Materials and Methods 
4.3.1 Animals  
Adult horses, quarantined for at least three weeks and determined to be healthy by physical 
examination and complete blood cell count, were used for the study. Throughout the study 
period, horses were offered hay and water ad libitum. At least 2 weeks prior to the study, horses 
were de-wormed with ivermectin (Eqvalan, Merial, Baie-d'Urfé, QC, Canada). Three days prior 
to surgery, horses were hospitalized to become acclimatized to their environment.  A physical 
examination was performed daily while the horses were hospitalized prior to surgery.  Horses 
were randomized to one of three groups using an on-line random number generator program 
(http://www.randomizer.org/form.htm).  One group received only a ventral midline celiotomy (n 
= 4, CEL), a second group received intestinal ischemia and reperfusion (n = 6, IR), and a third 
group received intestinal ischemia and reperfusion and were administered gadolinium chloride 
(GC) to deplete intravascular macrophages (n = 6, IRGC).  All procedures and experimental 
protocols were approved by the University of Saskatchewan Committee on Animal Care and 
Supply and the University of Saskatchewan Animal Research Ethics Board. 
4.3.2 Intestinal ischemia and reperfusion model and sample collection 
Forty-eight hours prior to surgery, a catheter was placed into the right jugular vein. Blood was 
collected for “pre” neutrophil isolation, measurement of plasma endotoxin and cytokines, and 
complete blood cell count.  Samples for plasma endotoxin quantification were prepared by 
aseptically collecting  6-ml of blood into endotoxin free tubes containing 
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ethylenediaminetetraacetic acid (Sarsdet, Montreal, QC, Canada), separating the plasma by 
centrifugation (100 x g for 10 min), diluting the plasma 1:10 with endotoxin free water (Lonza, 
Allendale, NJ, USA), and heat inactivating for 60°C for 15 min.  Presence of endotoxin in the 
plasma was detected at 0.06 EU/ml or 0.25 EU/ml using a commercially available limulus 
amebocyte assay (Lonza, Allendale, NJ, USA) using manufacturer’s directions. Gadolinium 
chloride (Sigma Aldrich Canada, Oaksville, ON, Canada) in 60 ml of 0.9% sodium chloride was 
administered twice to IRGC horses (10 mg/kg bwt i.v.), while CEL and IR groups received 60 
ml of 0.9% sodium chloride, 24 and 48 h pre-operatively.   
Horses were anesthetized, placed in dorsal recumbency on an equine surgical table, and 
the ventral abdomen was clipped and prepared for aseptic surgery.  A 25-cm incision was made 
along the ventral midline through the linea alba.  The peritoneal cavity was entered using blunt 
dissection.  For IR and IRGC horses, a 3-m section of jejunum was isolated 9-m oral to insertion 
of the ileocecal band on the proximal ileum.  Sterile 0.9% sodium chloride solution was used 
throughout the procedure to moisten the intestine.  Doyen intestinal clamps were placed across 
the lumen at each end of the isolated segment.  Mesenteric vessels were occluded with temporary 
ligatures of latex penrose drains and hemostatic forceps to induce ischemia.  After 2 h, the 
clamps and ligatures were removed. Celiotomies were closed routinely in 3 layers using various 
sutures sizes in a simple continuous pattern. Horses were allowed to recover unassisted from 
anesthesia. Following recovery from anesthesia, horses received butorphanol (Torbugesic,10 mg 
IM, Zoetis Canada, Kirkland, QC, Canada) every 4-6 h for pain management.  Horses exhibiting 
high levels of pain received a single dose of detomidine (Dormosedan,1 μg/kg bwt IV, Zoetis 
Canada, Kirkland, QC, Canada).  
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A physical examination was performed every 6 h post-operatively.  Blood was collected 
at 2 h and 6 h after the start of reperfusion for plasma endotoxin quantification and neutrophil 
isolation, respectively.  Plasma was collected at 2, 6, 12, and 18 h after the start of reperfusion 
and stored at -80°C until quantification of plasma cytokines including equine interleukin (IL)-1 
beta, equine tumor necrosis factor (TNF) alpha, equine IL-10, and human transforming growth 
factor-beta 1 (TGF-β1), was performed using commercially available enzyme-linked 
immunosorbent assays (ELISA) as per manufacturer directions (Duoset ELISA, R & D Systems, 
Minneapolis, MN, USA). At 18 h after ischemia, a post-operative complete blood cell count was 
performed and horses were euthanized with an overdose of pentobarbital.  
Lung samples were collected and fixed as previously described (Johnson et al. 2014).  
Briefly, the left lung was fixed in situ by instilling 0.1% glutaraldehyde, 4% paraformaldehyde in 
4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) into the left main bronchus, 
clamping the bronchus, and submerging the lung in an air-tight plastic bag.  After 24 h of 
fixation at 4ºC, the left lung was sectioned by a randomized fractionation method to achieve 
appropriate sized tissue for paraffin embedding.  Samples of the right lung and intestine were 
fixed by submersion in 4% paraformaldehyde in phosphate buffered saline (PBS).  After 24 h of 
fixation at 4ºC, tissues were trimmed, dehydrated, and embedded in paraffin.  Tissues were 
sectioned at a thickness of 7 μm.  Additional samples of lung and intestine, from lesion and non-
lesion areas of jejunum, were snap frozen on dry ice and stored at -80ºC. 
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4.3.3 Assessment of pulmonary inflammation and presence of pulmonary intravascular 
macrophages  
 4.3.3.1 Lung histology 
Multiple lung sections from the cranial and caudal lobes of the left and right lungs were stained 
routinely with hematoxylin and eosin (H and E).  A pathologist, blinded to treatment group, 
examined all sections by light microscopy.  Lung sections were graded on a scale of 0-3 (0 = 
absent, 1 = mild, 2 = moderate, 3 = severe) for degree of inflammation based on amount of 
edema, septal thickening, and cellular infiltration.   
4.3.3.2 Myeloperoxidase activity in lung samples 
Myeloperoxidase (MPO) activity was assessed in fresh frozen lung tissues.  Briefly, 500 mg of 
tissue was homogenized in 50 mM HEPES (Sigma-Aldrich Canada, Oakville, ON) using 
stainless steel beads (Qiagen Sciences, Germantown, MD).  Tissues were re-homogenized to lyse 
cells in 0.5% cetyltrimethylammoniumchloride (Sigma-Aldrich Canada, Oakville, ON).  
Supernatants were diluted 1:50 in phosphate citrate buffer and protein concentration in 
supernatants was quantified using a commercial kit (DC™ Protein Assay, Bio-Rad Laboratories, 
Mississauga, ON, Canada).  Diluted samples were incubated for two minutes with substrate 
solution containing resorcinol (Fischer Scientific Company, Ottawa, ON), tetramethylbenzidine 
(Sigma-Aldrich Canada, Oakville, ON), and hydrogen peroxide (Sigma-Aldrich Canada, 
Oakville, ON) in distilled water in a 96-well plate.  The reaction was stopped with sulfuric acid 
and the color change was measured at an absorbance of 405 nm using a microtiter plate reader.  
Results for MPO activity was compared to a standard of known MPO concentration and 
corrected for protein concentration in the sample. 
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4.3.3.3 Immunostaining with anti-macrophage antibody 
Lung sections were deparaffinized and fixed with ethanol.  Endogenous peroxidase activity was 
inhibited (0.5% hydrogen peroxide in methanol) before incubating in pepsin to unmask antigens 
(2mg/ml pepsin in 0.01N HCl).  Tissues were incubated in pepsin at room temperature for 60 
minutes.  Non-specific binding was blocked using bovine serum albumin (1% in PBS buffer) for 
30 minutes prior to application of primary antibodies. Lung sections were evaluated for the 
primary antibody anti-human macrophage IgG1 antibody (MAC387, AbD Serotec®, Raleigh, 
NC, USA), an antibody that binds to calprotectin, a protein present in many inflammatory cells 
including macrophages and neutrophils.  This antibody has previously been used to identify 
equine pulmonary intravascular macrophages (Parbhakar et al. 2005, Schneberger et al. 2012). 
Following incubation with the primary antibody overnight at 4oC, horseradish peroxidase (HRP)-
conjugated secondary antibodies were applied and incubated at room temperature for 30 minutes.  
Color was developed using a substrate peroxidase kit (Vector Laboratories, Ontario, Canada), 
washed, and counterstained with methyl green (Vector Laboratories, Ontario, Canada).  Two 
negative controls were prepared by omitting the primary or secondary antibody and an isotype 
control was prepared for the primary antibody.  The primary antibody concentration was 
standardized using three serial concentrations.  Mononuclear cells stained positive for MAC387 
were counted by an observer blinded to treatment in 10 fields at 60x magnification in at least 3-4 
different lung sections.  Cells were counted only within the alveolar septum and mononuclear 
cells were differentiated from polymorphonuclear cells by nuclear morphology. 
 4.3.3.4 Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL)  
The TUNEL assay was performed using a commercially available kit per manufacturer’s 
directions (Roche Applied Science, Laval, QC, Canada) to determine the extent of apoptosis in 
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PIMs. Briefly, lung sections were deparaffinized and fixed with ethanol.  Tissues were 
permeabilized with proteinase K (20 μg/ml in 10 mM TrisHcl, Sigma-Aldrich Canada, Oakville, 
ON) for 30 minutes at 37°C.  The TUNEL enzyme solution was diluted to 1:10 with label 
solution.  Tissues were incubated with the diluted enzyme solution for one hour at 37°C.  The 
slides were washed and the fluorescent signal was converted to a color signal using 
manufacturer’s directions.  A negative control was prepared by eliminating the enzyme solution.  
TUNEL stained cells were counted by an observer blinded to treatment in 10 fields at 60x 
magnification in at least 3-4 different lung sections.  Only cells contained within the alveolar 
septum were counted. 
4.3.4 Assessment of intestinal inflammation 
4.3.4.1 Intestine histology 
Intestinal sections were stained routinely for hematoxylin and eosin (H and E).  A pathologist, 
blinded to treatment group, examined all sections by light microscopy.  Intestinal sections were 
graded on a scale of 0-3 (0 = absent, 1 = mild, 2 = moderate, 3 = severe) for degree of 
inflammation.  The presence of villous atrophy, epithelial degeneration, and hemorrhage were 
evaluated with a yes/no score.  Predominate infiltrating cell type was also recorded.   
4.3.4.2 Myeloperoxidase activity in intestine samples 
MPO activity was measured in intestinal samples using the same protocol as for lung samples. 
4.3.5 Neutrophil isolation and culture 
Neutrophils were isolated using a previously reported protocol with minor modification (Cook et 
al. 2009).  Blood was collected aseptically from a jugular vein into vacuum tubes containing 
EDTA (EDTA, Vacutainer™, BD, Mississauga, ON, Canada).  Isolation was performed at room 
temperature (20-22°C) immediately after blood collection.  The blood was allowed to separate 
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into plasma and red cell fractions for 30-45 min at room temperature.  Plasma was layered onto 
10 ml Ficoll-Paque Plus (GE Healthcare, Mississauga, ON, Canada) and centrifuged for 30 min 
at 400 x g.  The subsequent pellet, containing erythrocytes and granulocytes, was retained after 
aspirating the supernatant and washed with Hank’s Buffered Salt Solution (pH 7.4, HBSS) 
without phenol, magnesium, or calcium for 10 min at 200 x g.  Erythrocytes were lysed with 
sterile distilled water for 25 s and restored to normotonicity with an equal volume hypertonic 
(2x) HBSS.  Cells were washed 3 times with HBSS at 200 x g for 10 min, suspended in culture 
medium (Roswell Park Memorial Institute (RPMI) 1640 medium containing 10% fetal bovine 
serum, 2 mM L-glutamine, 100 IU/ml penicillin, 50 μg/ml streptomycin, and 25 mM HEPES, 
Lonza BioWhittaker®, VWR, Edmonton, AB, Canada) assessed for viability using trypan blue 
staining, and counted with a hemocytometer.  Cell purity was determined on cytology 
preparations made with a cytocentrifuge (Shandon Cytospin 4, Thermo Scientific, Waltham, 
MA, USA) at 1000 rpm for 4 min with medium acceleration and stained with a modified Giemsa 
stain (Hemacolor® EMD chemical, Gibbstown, NJ).  
Neutrophils were suspended in culture medium in plastic multi-well cell culture plates at 
a standard concentration of 2 x 106 cells/ml and cells were incubated at 37°C in 5% CO2.  To 
assess the effect of gadolinium chloride on neutrophil apoptosis, cells were treated in culture 
with 270 μM gadolinium chloride or were left untreated for 24 h.  For ex vivo experiments, 
neutrophils isolated before and after surgery were cultured for 12 or 24 h.  Prior to performing 
apoptosis assays, neutrophils were taken out of culture, pelleted, and washed twice with HBSS at 
300 x g for 8 min.   
 
 
70 
 
4.3.6 Apoptosis assays 
4.3.6.1 Flow cytometry 
Neutrophils (1 x 106 cells/ml) were stained with CF488-conjugated Annexin V (AV) and 
propidium iodide (PI) apoptosis kit per manufacturer’s instructions (CF™488A-Annexin V and 
PI Apoptosis Assay Kit, Biotium, Hayward, CA, USA).  Staining controls included unstained 
untreated cells, untreated cells stained with AV only, and untreated stained with PI only. A flow 
cytometer (CyFlow®, Partec, Swedesboro, NJ, USA) was used to count negatively stained (live 
cells), AV positively stained (apoptotic cells), or AV and PI positively stained (dead) cells. Flow 
cytometry data were analyzed with commercial software (FlowMax Software© Version 2.6, 
Quantum Analysis GmbH, Münster, Germany).  The gated population was determined with 
unstained cells based on size (forward scatter) and granularity (side scatter).  Quadrants were 
determined using untreated cells stained with only AV or PI. Data were acquired on at least 
10,000 gated events.   
4.3.6.2 Caspase activity assay 
Caspase-3, -8, and -9 activities were indirectly measured using a commercially available 
colorimetric assay kit per manufacturer’s instructions (Caspase-3, -8, or -9 Colorimetric Assay 
Kit, Biovision, Milpitas, CA, USA).  Caspase-3 activity was measured to determine overall 
apoptotic activity.  Caspase-8 activity was measured to assess the contribution of the extrinsic 
pathway and Caspase-9 activity was measured to assess the contribution of the intrinsic pathway 
on the occurrence of neutrophil apoptosis.  At least 1 x 106 neutrophils were lysed using the 
manufacturer’s lysis buffer following removal from culture and washing as described above. Cell 
lysates were stored at -80°C until processing.  Upon thawing, protein concentration in cell 
lysates was quantified using a commercial kit (DC™ Protein Assay, Bio-Rad Laboratories, 
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Mississauga, ON, Canada). Cell lysates were incubated with the manufacturer’s reaction buffer 
containing dithiothreitol (DTT) and each Caspase’s substrate: DEVD-pNA (Caspase-3), IETD-
pNA (Caspase-8), or LEHD-pNA (Caspase-9) in 96-well plates for 2 h at 37°C. Immediately 
after incubation, free pNA was quantified by measuring absorbance at 405 nm in a microtiter 
plate reader. Levels of free pNA were corrected for protein concentration in cell lysates.  
4.3.7 Statistical analysis 
Data were analyzed with commercial software packages (StataIC 13, StataCorp, College Station, 
TX, USA and Graphpad Prism, Graphpad Software, Inc. La Jolla, CA, USA).  For all 
comparisons, a P-value of < 0.05 was considered significant. Differences in physical 
examination parameters and plasma cytokine concentrations over time were compared among 
groups using a repeated-measure ANOVA.  Differences in physical examination parameters and 
plasma cytokine concentrations from baseline within a group and differences in physical 
examination parameters and plasma cytokine concentrations among groups at each time point 
were analyzed using a Kruskal-Wallis rank test with a Dunn’s multiple comparisons test.  
Difference in complete white cell and neutrophil counts before and after surgery was assessed for 
each group by comparing the difference in the means before and after surgery using a one-sided 
t-test.  Difference in complete white cell and neutrophil counts among groups was assessed using 
a Kruskal-Wallis rank test with a Dunn’s multiple comparisons test. A Kruskal-Wallis rank test 
with a Dunn’s multiple comparisons test was used to assess differences in histology scores, MPO 
activity, MAC387 staining, and TUNEL staining among groups.  A Wilcoxon rank sum test was 
used to compare inflammation scores and MPO activity between lesion and non-lesion intestinal 
samples within the IR and IRGC groups. To assess differences in ex vivo neutrophil apoptosis 
and caspase activity before and after surgery within a group, difference in the means were 
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calculated from before and after surgery, then a one-sided t-test was performed. Differences in ex 
vivo neutrophil apoptosis and caspase activity among groups, before or after surgery, were 
assessed with a Kruskal-Wallis rank test with a Dunn’s multiple comparisons test. A Mann-
Whitney U test was used to assess the effect of treatment with gadolinium chloride on in vitro 
neutrophil apoptosis.   
4.4 Results 
4.4.1 Clinical data 
All horses exhibited various clinical signs of a systemic inflammatory response, including 
depression, tachycardia, hyperthermia, and to a lesser extent tachypnea at some point post-
operatively. There was no difference in body temperature, heart rate, or respiratory rate among 
groups at any single time point or over time after surgery (Figure 4.1).  Body temperature was 
significantly elevated above baseline for IR and IRGC horses at 12 h post-reperfusion (IR: P < 
0.001, IRGC: P = 0.002, Figure 4.1). Heart rate was significantly elevated from baseline in CEL 
and IR horses at 12 h post-reperfusion (CEL: P = 0.008, IR: P = 0.002, Figure 4.1).  Respiratory 
rate was not different from baseline in any group (Figure 4.1). Horses in the CEL and IRGC 
groups had a significant increase in total white blood cell count after surgery (CEL: P = 0.02, 
IRGC: P = 0.008, Figure 4.2), but all groups had a significant increase in total circulating 
neutrophils after surgery (CEL: P = 0.007, IR: P = 0.01, IRGC: P = 0.0006, Figure 4.2).  There 
was no difference in total white cell counts or neutrophils counts among groups before or after 
surgery.  There was no difference over time for IL-1β, TNF-α, IL-10, or TGF-β concentrations 
among groups.  IRGC horses had greater plasma IL-1β concentration compared to IR horses 18 h 
after surgery (P = 0.03, Figure 4.3) and greater TNF-α concentrations compared to IR horses 2 
and 6 h after surgery (2 h: P = 0.03, 6 h: P = 0.03, Figure 4.3).  In IRGC horses, TNF-α was 
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significantly increased from baseline at post-reperfusion hours 6, 12, and 18 and IL-10 was 
significantly decreased from baseline at post-reperfusion hours 12 and 18 h (P < 0.05, Figure 
4.3).  No horses had measurable endotoxin (>0.06 EU/ml) in their plasma before surgery or 2 h 
after the start of reperfusion. 
4.4.2 Intestinal ischemia and reperfusion failed to induce significant intestinal inflammation or 
remote lung injury   
There was no difference among groups for total pulmonary inflammatory scores or lung MPO 
activity (Figure 4.4a).  There was no difference among groups for total intestinal inflammation 
scores or intestine MPO activity (Figure 4.4b).  Additionally, there was no difference in total 
intestinal inflammation scores or MPO activity between lesion and non-lesion areas of jejunum 
with IR and IRGC groups.  The primary infiltrating cell type in areas of the IR lesion consisted 
of lymphocyte plasma cells. 
4.4.3 Treatment with gadolinium chloride reduces MAC387 positive mononuclear cell 
infiltration associated with intestinal ischemia and reperfusion 
There was no difference in histologic grades of lung inflammation among groups and, overall, 
horses had very mild pulmonary inflammation (Figure 4.5a). There were significantly fewer 
alveolar septal mononuclear cells in pulmonary sections from IRGC compared with IR horses 
following intestinal ischemia and reperfusion (P = 0.02, Figure 4.5b).  There was no difference 
in TUNEL positive cells within the alveolar septum among groups (Figure 4.5c). 
4.4.4 Ex vivo neutrophil apoptosis is reduced following surgery due to reduced caspase activity 
except in horses treated with gadolinium chloride 
There was no difference among percentage of apoptotic neutrophils as measured by flow 
cytometry immediately after isolation before and after surgery for each group (Figure 4.6). 
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However, there was a significant reduction in caspase-3 activity in freshly isolated (0 h 
incubation) neutrophils in the IR group, but not the CEL and IRGC groups post-operatively (P = 
0.03, Figure 4.7).   
Neutrophil apoptosis was significantly delayed ex vivo after 12 or 24 h of culture in 
neutrophils isolated from horses after the induction of systemic inflammation compared to 
baseline for all groups, except IRGC (12 h: CEL: P = 0.03, IR: P = 0.05, IRGC: P =0.2; 24 h: 
CEL: P = 0.001, IR: P = 0.004, IRGC: P = 0.3, Figure 4.6).  There was no difference in the 
occurrence among groups pre- or post-operatively; however when IR and IRGC groups were 
compared without CEL group, IRGC horses had greater percentage of apoptotic neutrophils in 
post-operative samples incubated for 24 h (P = 0.04, Figure 4.6). 
Caspases are important proteases involved in both the classical intrinsic and extrinsic 
pathways of apoptosis.  Caspase-3 is the end effector caspase for both pathways, caspase-8 is an 
initiator caspase involved in the extrinsic pathway, and caspase-9 is an initiator caspase involved 
in the intrinsic pathway.  Caspase-3, -8, and -9 activities were reduced in neutrophils isolated 
from IR horses after surgery compared to before surgery (caspase-3: P = 0.002, caspase-8: P = 
0.002, caspase-9, P = 0.04, Figure 4.7).  Horses in the CEL group only had reduced caspase-3 
activity after surgery as compared to before surgery (P = 0.04, Figure 4.7), while caspase activity 
was not reduced in IRGC horses.   
4.4.5 Gadolinium chloride does not affect the occurrence of neutrophil apoptosis in vitro 
When neutrophils were incubated with concentrations of gadolinium up to 270 μM for 24 hours, 
there was no effect on the occurrence of apoptosis compared to untreated cells (P = 0.39, Figure 
4.8). 
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Figure 4.1.  Physical examination parameters recorded following surgery for sham celiotomy 
(CEL) or intestinal ischemia and reperfusion (IR) or IR with administration of gadolinium 
chloride (IRGC).  Data represents the median with range. Differences for each group’s 
parameters for each time point compared to baseline and difference among groups at each time 
point was assessed with a Kruskal-Wallis rank test with a Dunn’s multiple comparisons test. 
Difference among groups over time for each physical examination parameter was analyzed with 
a repeated-measure ANOVA.  Stars represent difference from baseline (*P<0.05, **P<0.01). 
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Figure 4.2. Total white blood cell counts and total neutrophil counts for horses receiving sham 
celiotomy (CEL) or intestinal ischemia and reperfusion without (IR) or with administration of 
gadolinium chloride (IRGC) before and after surgery.  Bar represents the median. Difference in 
the means before and after surgery was assessed using a one-sided t-test.  Difference groups 
before and after surgery was assessed using a Kruskal-Wallis rank test with a Dunn’s multiple 
comparisons test. 
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Figure 4.3.  Plasma cytokine concentrations for horses receiving sham celiotomy (CEL) or 
intestinal ischemia and reperfusion without (IR) or with administration of gadolinium chloride 
(IRGC) before and after surgery. Difference among groups at each time point and difference 
within a group among time points were assessed with a Kruskal-Wallis rank test with a Dunn’s 
multiple comparisons test.  Difference among groups over time for each cytokine was analyzed 
with a repeated-measure ANOVA.  Data represent median and range. Stars represent 
significance from pre-operative values (P < 0.05). 
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Figure 4.4.  Assessment of pulmonary and intestinal inflammation.  a) Representative 
photomicrographs of pulmonary H & E stained slides, total lung inflammation scores, and lung 
MPO activity. b) Representative photomicrographs of intestinal H & E stained slides, total 
intestinal inflammation scores, and intestinal MPO activity.  Difference among groups was 
assessed with Kruskal-Wallis rank test with a Dunn’s multiple comparisons test.  Difference 
between lesion and non-lesion inflammation scores were compared for each group using a 
Wilcoxon Rank Sum Test.  Data are represented by the median and range.  Bar represents the 
median. 
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Figure 4.5 Parenteral administration of gadolinium chloride reduces mononuclear cell infiltration 
associated with intestinal ischemia and reperfusion.  Photomicrographs of representative 
pulmonary sections stained with a) calprotectin (MAC387) or against b) TUNEL with 
corresponding positive cell counts in 10 fields counted at 60x. Data are represented by the 
median and range. Data were analyzed using a Kruskal-Wallis rank test with a Dunn’s multiple 
comparisons test. 
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Figure 4.6 Ex vivo neutrophil apoptosis is delayed following surgery, except in horses 
administered parenteral gadolinium chloride.  Differences in mean occurrence of apoptosis 
before and after surgery were calculated then a one-sided t-test was performed to assess 
difference before and after surgery within a group.  A Kruskal-Wallis rank test with a Dunn’s 
multiple comparisons test was used to assess difference among groups in the occurrence of 
neutrophil apoptosis before or after surgery.  For 24 h incubation, IR and IRGC groups were 
compared without CEL group using a Mann-Whitney U test. Bar represents the median. 
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Figure 4.7 Neutrophil caspase activities are reduced in horses undergoing celiotomy and 
intestinal ischemia and reperfusion, but not in horses that received parenteral gadolinium 
chloride.  Differences in mean occurrence of apoptosis before and after surgery were calculated 
then a one-sided t-test was performed to assess difference before and after surgery within a 
group.  A Kruskal-Wallis rank test with a Dunn’s multiple comparisons test was used to assess 
difference among groups in caspase activity. Data are represented by the median and range. 
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Figure 4.8 Gadolinium chloride treatment has no effect on the occurrence of neutrophil apoptosis 
in vitro.  Data were analyzed with a Mann-Whitney U test and is represented by the median (n = 
6 horses). 
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4.5 Discussion 
This study supports our hypothesis that ex vivo neutrophil apoptosis is delayed following 
intestinal IR due to reduced caspase activity and parenteral administration of GC reduced 
delayed ex vivo neutrophil apoptosis and reduced pulmonary mononuclear infiltration into the 
lung following intestinal IR; however, treatment with GC did not alter the measured parameters 
of systemic inflammation. In addition, control horses undergoing a sham celiotomy unexpectedly 
experienced a mild systemic inflammatory response and delayed ex vivo neutrophil apoptosis 
following surgery. 
Gadolinium chloride is a chemical that may be used to preferentially inactivate and 
deplete intravascular macrophages, specifically equine PIMs, with the intent to study the 
contribution of these cells to inflammatory processes in horses (Parbhakar et al. 2005). GC 
causes mononuclear cell apoptosis in a dose- and time-dependent manner starting 8 h after 
administration with near complete depletion occurring by 72 h (Mizgerd et al. 1996, Parbhakar et 
al. 2005).  In our horses, treatment with GC significantly reduced mononuclear cell counts in 
lungs of horses that underwent IR, representing the first time this has been observed in an equine 
systemic inflammatory model. The reduction in mononuclear cell counts could be due to 
depletion of constitutive PIMs and reduced infiltration of new cells following induction of IR. 
However, there was no difference in the number of apoptotic septal cells within the lung as 
demonstrated by TUNEL staining. This finding could be explained by the fact that PIMs were 
already dead, having been depleted by two doses of GC administered 66 and 42 hours prior to 
euthanasia and lung fixation, rather than apoptotic, which is required for positive TUNEL 
staining. Nevertheless, the use of GC resulted in significant depletion of PIMs in IR horses. 
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 Contrary to another study published by our research group, horses in this study did not 
develop significant pulmonary inflammation following intestinal ischemia and reperfusion or 
anesthesia (Montgomery et al. 2014). One explanation for this difference is that samples in the 
previous report were taken one hour after the start of reperfusion; whereas, the samples in the 
current study were taken 18 hours following reperfusion, potentially giving the lung time to 
“recover” from the effects of anesthesia and remote injury.  Even so, the majority of lungs had 
evidence of dorsal bruising at necropsy, which would be considered a normal sequela to 
undergoing prolonged anesthesia in dorsal recumbency in the horse.   
 In addition to the lack of pulmonary inflammation, there was an unexpected lack of 
inflammation on histologic examination in areas of the jejunum that experienced ischemia and 
reperfusion despite grossly visible lesions observed at necropsy.  In addition, the primary 
infiltrating cell types consisted of lymphocytes and plasma cells, which is different than the 
previously reported primary infiltrating cell type of neutrophils (Cook et al. 2009, Little et al. 
2005).  Despite the lack of local inflammation observed in intestinal and pulmonary tissues, 
horses did develop a systemic inflammatory response following surgery that met the criteria of 
SIRS. 
It has been demonstrated in multiple models and clinical cases, that SIRS delays 
neutrophil apoptosis in humans and laboratory mammals (Fanning et al. 1999, Jimenez et al. 
1997, Shang et al. 2007). Though all horses in this study experienced only a mild systemic 
inflammatory response with minimal local intestinal inflammation, they would have met the 
classification for SIRS (having 2 of the following:  tachycardia, tachypnea, fever, leukopenia or 
leukocytosis with or without a left shift) between12-18 h post-operatively. Concomitantly, there 
was a significant delay in ex vivo neutrophil apoptosis in neutrophils isolated following surgery 
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in CEL and IR horses, but not IRGC horses, due to reduced intrinsic and extrinsic caspase 
activity. 
Despite failing to identify the precise mechanism of delayed ex vivo neutrophil apoptosis 
following intestinal IR, we were able to determine that delayed ex vivo neutrophil apoptosis 
following the induction of systemic inflammation from intestinal IR involved reduction in both 
intrinsic (caspase-9) and extrinsic (caspase -8) initiator caspase activities that likely culminated 
in a significant reduction in effector caspase-3 activity based on known pathways of apoptosis 
(Figure 4.9).  These data suggest that both the intrinsic and extrinsic pathways of apoptosis are 
affected in neutrophils isolated from horses experiencing intestinal IR.  Similarly, in humans, 
delayed ex vivo neutrophil apoptosis in neutrophils isolated from septic patients, who are 
invariably experiencing concurrent SIRS, was associated with reduced caspase-3 and -9 activities 
(Taneja et al. 2004).   
This is the first report investigating the role of PIMs in the modulation of neutrophil 
apoptosis.  The parenteral administration of GC rescued ex vivo delayed neutrophil apoptosis, 
apparently through less suppression of caspase-3, -8, and -9 activities allowing neutrophils to 
undergo apoptosis in vitro at a similar rate as before surgery.  However, GC had no effect on the 
occurrence of in vitro neutrophil apoptosis or in vitro neutrophil caspase activity (data not 
shown).  Further investigation is warranted to characterize the role of PIMs in modulating 
neutrophil lifespan. 
 We have demonstrated that delayed ex vivo equine neutrophil apoptosis is associated 
with the development of SIRS; and due to the multifactorial etiology of SIRS the exact cause of 
delayed ex vivo neutrophil apoptosis cannot be surmised from the data collected in this study; 
however, certain causes may be ruled out or postulated.  First, it is possible that delayed ex vivo 
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neutrophil apoptosis was independent of endotoxemia as our horses did not have measurable 
endotoxin 2 h after the start of reperfusion.  It is also possible that the development of 
endotoxemia could have been missed due to incorrect time of sampling.   However, we chose the 
time point based on work performed by Moore et al. (1981), where they quantified endotoxin at 
60 and 120 minutes following the start of intestinal reperfusion after 50 or 180 minute period of 
ischemia.  In a clinical study, the sensitivity and specificity of detecting endotoxin in the plasma 
of horses that were clinically classified as being endotoxic was only 58.4% and 87.5%, 
respectively, suggesting that plasma endotoxin quantification is not straightforward or the term 
endotoxemia is improperly used in clinical cases where horse are experiencing SIRS rather than 
endotoxemia (Moore and Vandenplas 2014, Senior et al. 2011).  Endotoxemia is transient as LPS 
is rapidly removed from the equine blood compartment (Fessler et al. 1989), so ideally multiple 
samples should have been collected over time to more accurately measure the presence of 
endotoxin in the plasma in the horses in this study.  Furthermore, there may other microbial 
molecules in the blood of horses experiencing IR that may activate neutrophils, similarly to LPS.  
Second, the cytokine profile was opposite of what was expected given the ex vivo 
neutrophil apoptosis results; namely, IRGC horses had greater concentrations of IL-1β and TNF-
α compared to IR horses post-operatively with a concomitant reduction in IL-10 concentration 
from baseline.  Unfortunately, there is a distinct void in the equine literature on the plasma 
cytokine profile of horses undergoing experimental intestinal ischemia and reperfusion, so we 
cannot relate our results to previous studies.  In a rat model of intestinal ischemia and 
reperfusion, plasma concentrations of IL-1β and TNF-α peaked at 1 h and 3 h, respectively, 
which is much sooner than what we measured in horses undergoing intestinal ischemia and 
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reperfusion, but is similar in the fact that IL-1β peaks prior to TNF-α (Guzma´n-de la Garza et al. 
2013).   
Inflammatory cytokines, including IL-1β and TNF-α, have been shown to delay 
neutrophil apoptosis in vitro (Colotta et al. 1992).  However, we have failed to delay equine 
neutrophil apoptosis with treatment of recombinant equine IL-1β in vitro (unpublished data) and 
TNF-α has been shown to have variable effects on neutrophil apoptosis depending on 
concentration and time of exposure (Cross et al. 2008, Fox et al. 2010, Murray et al. 1997, 
Salamone et al. 2001).  In fact, early exposure to low concentrations of TNF-α induces 
neutrophil apoptosis; and when neutrophils are pre-treated with TNF-α, apoptosis is accelerated 
when exposed to substances that commonly delay neutrophil apoptosis, such as Escherichia coli 
(Salamone et al. 2001). In IRGC horses, TNF-α concentrations increased from 2 h up to the last 
time point measured at 18 h post-reperfusion; whereas TNF-α concentrations started to increase 
in IR horses at 12 h post-reperfusion.  Given that neutrophils were isolated 6 h post-reperfusion, 
when TNF-α was beginning to increase in IRGC horses and not measurable in IR horses, 
variable effects of TNF-α on neutrophil lifespan would be expected.  In IRGC horses, 
neutrophils were being exposed to a low level of TNF-α during the early inflammatory phase, 
which may have contributed to the observed difference in ex vivo neutrophil apoptosis. 
Additionally, IL-1β and TNF-α activate equine neutrophils to promote reactive oxygen species 
(ROS) production (Benbarek et al. 2008).  It is currently thought that most of the molecular 
pathways causing neutrophil apoptosis are dependent upon ROS generation; however, ROS can 
have alternative effects on neutrophils, such as interference with caspase activities causing 
delayed apoptosis or the initiation of cell necrosis rather than apoptosis (Fadeel et al. 1998, 
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Geering and Simon 2011, Scheel-Toellner et al. 2004).  Based on our results, the effect of TNF-α 
and ROS production on equine neutrophil apoptosis deserves further evaluation.  
It has previously been shown by our research group that depletion of PIMs reduces the 
expression of IL-1β and TNF-α in lung cells following parenteral endotoxin challenge; however, 
circulating cytokines were not measured (Parbhakar et al. 2005).  Our findings suggest that PIMs 
are not a primary source of circulating cytokines during inflammatory processes.  However, it is 
possible that by depleting PIMs a shift toward resolution of inflammation may have been 
impaired within the scope of the inflammatory response, which could explain why IRGC horses 
experienced similar signs of systemic inflammation as IR horses and why the inflammatory 
cytokines, TNF-α and IL-1β, were elevated and the anti-inflammatory cytokine, IL-10, was 
reduced in IRGC.  For example, in mice depleted of intravascular macrophages and subjected to 
intestinal ischemia and reperfusion, TNF was increased and IL-10 was decreased compared to 
non-depleted mice (Ellet et al. 2010). Additionally, because PIMs are important for removal of 
foreign entities, such as LPS, from the bloodstream, their depletion could result in a greater 
inflammatory response. Further work is needed to elucidate the plasma cytokine profile, both 
pro- and anti-inflammatory, in horses undergoing inflammatory models to provide a basis from 
which modulation of the innate immune response can be assessed. 
Third, another contributor to delayed neutrophil apoptosis, which has received limited 
investigation, has been coined the “community effect,” whereby neutrophil apoptosis is delayed 
by increased concentration and density in vitro (Attalah et al. 2012, Hannah et al. 1998).  To the 
authors’ knowledge, concentration- and density-delayed neutrophil apoptosis have not been 
studied in vivo nor have they been investigated in equine neutrophils; however, the results of our 
study, where horses experienced a significant increase in circulating neutrophil concentrations 
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after surgery and concomitant delayed ex vivo apoptosis without measurable plasma endotoxin, 
support this mechanism of delayed neutrophil apoptosis.  Indeed, we have supporting data that 
demonstrate the occurrence of equine neutrophil apoptosis is concentration dependent in vitro 
(Chapter 5). 
Finally, there are other inflammatory mediators that were not measured in this study that 
might have contributed to the observed delay in ex vivo neutrophil apoptosis in CEL and IR 
horses.  Granulocyte macrophage-colony stimulating factor (GM-CSF) is a powerful inhibitor of 
neutrophil apoptosis and has been shown to play a significant role in SIRS-delayed neutrophil 
apoptosis in vivo (Fanning et al. 1999).  Also, complement 5a (C5a) has been identified as a key 
mediator of delayed neutrophil apoptosis in septic rats and human patients (Guo et al. 2006, 
Unnewehr et al. 2013).   
It is important to notice that horses in the CEL group also experienced a significant 
increase in systemic neutrophils and delayed ex vivo neutrophil apoptosis, even though they were 
considered to be controls.  This observation serves two purposes, first it highlights the need for 
appropriate controls in inflammatory models.  To the authors’ knowledge, this is the first study 
that has included a sham celiotomy group in an equine intestinal IR model.  Secondly, it is 
important to realize that performing any type of surgery will lead to some amount of systemic 
inflammatory response, which could explain, in part, why Krista et al. failed to show a difference 
in the occurrence of ex vivo neutrophil apoptosis between horses undergoing elective orthopedic 
procedures and abdominal exploratory surgery (Krista et al. 2013). 
In conclusion, the induction of systemic inflammation in horses undergoing celiotomy 
and intestinal ischemia and reperfusion resulted in delayed ex vivo neutrophil apoptosis via 
down-regulation of caspase activity. Ultimately, delayed neutrophil apoptosis may have a 
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significant impact on the progression of many inflammatory disease processes due to the 
potential for inadvertent tissue damage to occur during neutrophil activation and the reduction of 
apoptotic neutrophils that are necessary for macrophage-driven resolution of inflammation.  
Therefore, the selective induction of neutrophil apoptosis could prove to be a potential 
therapeutic target to treat diseases associated with excessive neutrophil activation and 
accumulation, such as SIRS. 
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Figure 4.9 Potential mechanism for delayed ex vivo equine neutrophil apoptosis following 
intestinal ischemia and reperfusion.  
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CHAPTER 5: EX VIVO NEUTROPHIL APOPTOSIS IS 
DELAYED IN AN EQUINE COLITIS MODEL 
5.1 Abstract 
Horses that develop colitis invariably exhibit signs of a systemic inflammatory response 
syndrome (SIRS).  A significant contributor to the development of SIRS in humans is delayed 
neutrophil apoptosis, but this has not been specifically studied in horses.  The objective of this 
study was to evaluate the occurrence of ex vivo neutrophil apoptosis upon the SIRS from an 
equine colitis model.  Neutrophils were isolated before and after the induction of colitis using an 
oligofructose-overdose model, placed into culture for 12 or 24 h with or without 
lipopolysaccharide (LPS), and then assessed for the occurrence of apoptosis using Annexin V 
and propidium iodide staining with flow cytometric quantification.  Caspase-3, -8, and -9 
activities were measured after 12 h of incubation.  Ex vivo neutrophil apoptosis was significantly 
delayed in neutrophils isolated after the induction of colitis (12 h incubation: P = 0.004, 24 h 
incubation: P = 0.003) with concomitant reduction in caspase-3, -8, and -9 activities (caspase-3: 
P = 0.004, caspase-8: P = 0.02, caspase-9: P = 0.02). The data show that neutrophil apoptosis is 
delayed in horses with induced colitis, which may contribute to the development of SIRS. 
5.2 Introduction 
Horses experiencing colitis are at increased risk of developing a systemic inflammatory response 
syndrome (SIRS), an overzealous inflammatory response that is associated with increased 
morbidity and mortality (Moore and Vandenplas 2014).  SIRS in adult horses is defined using 
clinical parameters including hyperthermia, tachycardia, tachypnea, leukocytosis or leukopenia 
with a left shift, with only two of these parameters needing to be present to make a diagnosis of 
SIRS (Epstein et al. 2011, Moore and Vandenplas 2014). In cases of colitis, SIRS is thought to 
develop from endotoxin (bacterial lipopolysaccharide, LPS) entering the vascular compartment 
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from a compromised intestinal epithelial barrier (Senior et al. 2011).  Horses with colitis 
generally exhibit profound clinical signs of SIRS that may progress to multiple organ 
dysfunction syndrome (MODS), which in the horse is evidenced by the development of laminitis 
(Belknap 2009).  Indeed, models used to study laminitis include models of colitis, such as 
inducing colitis by oligofructose-overdose (Kalck et al. 2009, Nourian et al. 2007). 
In humans, circulating neutrophil apoptosis is delayed in patients experiencing SIRS and 
is thought to contribute to an inappropriate inflammatory response (Fanning et al. 1999, Jimenez 
et al. 1997, Paunel-Görgülü et al. 2012, Shang et al. 2007).  The increased life span of activated 
neutrophils is associated with exacerbation of inflammation and tissue damage caused by 
cytotoxic molecules released by the neutrophils. Furthermore, delayed efferocytosis of apoptotic 
neutrophils delays the initiation of macrophage-orchestrated resolution of inflammation (Fadok 
et al. 1998, Hofman 2004, Lucas et al. 2003, Wright et al. 2010).   
The cause of delayed neutrophil apoptosis in cases of SIRS may be from any number of 
substances that activate neutrophils, thereby prolonging their lifespan.  One substance that has 
been evaluated extensively in vitro for its effect on neutrophil lifespan and has been identified as 
a cause of SIRS in vivo is LPS (Colotta et al. 1992, Hofman et al. 2004, Sweeny et al. 1998, Sano 
et al. 2005).  The mechanism of LPS-delayed neutrophil apoptosis has been studied in humans 
and involves a shifting of balance from pro-apoptotic to anti-apoptotic processes of the intrinsic 
pathway of apoptosis via TLR4 activation (Edwards et al. 2004, François et al. 2005).  It is 
thought that LPS plays a significant role in delaying neutrophil apoptosis in human patients with 
sepsis and endotoxemia, both of which are also associated with the development of SIRS 
(Hofman 2004); however, this has not been demonstrated in the horse. 
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To the authors’ knowledge, ex vivo neutrophil apoptosis has not been examined in an 
equine model of colitis. We hypothesized that ex vivo apoptosis would be delayed in neutrophils 
isolated from horses following the induction of colitis by oligofructose overdose due to the 
development of SIRS and endotoxemia.  Therefore, our goal was to study the occurrence of ex 
vivo neutrophil apoptosis in horses before and after the induction of oligofructose-overdose 
colitis.  Additionally, we evaluated the effect of in vitro LPS treatment in neutrophils isolated 
before and after the induction of colitis and the effect of in vitro neutrophil concentration on the 
occurrence of apoptosis. 
5.3 Materials and methods 
5.3.1 Animals  
Adult horses, determined to be healthy by physical examination or complete blood cell count, 
were used for the study. Throughout the study period, horses were offered hay and water ad 
libitum.  Horses served as their own controls by comparing the occurrence of ex vivo apoptosis in 
neutrophils isolated before and after the induction of colitis.  All procedures and experimental 
protocols were approved by the University of Saskatchewan Committee on Animal Care and 
Supply and the University of Saskatchewan Animal Research Ethics Board. 
5.3.2 Oligofructose-induced colitis model 
Blood was collected for neutrophil isolation immediately prior to sedation with xylazine (0.5 
mg/kg IV).  Horses were administered an overdose of oligofructose (10 g/kg bwt) dissolved in 
water via nasogastric tube.   Colitis developed over the next 12-15 hours.  Blood was collected 
18-20 h after oligofructose administration for neutrophil isolation.  In 6 horses, blood was 
collected for complete blood count and plasma endotoxin quantification before and 18-20 h after 
oligofructose overdose.  For plasma endotoxin quantification blood was collected aseptically 
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from a jugular vein into endotoxin free tubes containing ethylenediaminetetraacetic acid (EDTA, 
Sarsdet, Montreal, QC, Canada).  Plasma was separated by centrifugation (100 x g for 10 min), 
diluted 1:10 with endotoxin free water (Sigma Aldrich Canada, Oaksville, ON, Canada), and 
heat inactivated for 60°C for 15 min.  Presence of endotoxin in the plasma was detected at 0.25 
EU/ml concentration using a commercially available limulus amebocyte assay using 
manufacturer’s directions (Lonza, Allendale, NJ, USA). 
5.3.3 Neutrophil isolation 
Neutrophils were isolated using a previously reported protocol with minor modification (Cook et 
al. 2009).  Blood was collected aseptically from a jugular vein into vacuum tubes containing 
EDTA (Vacutainer™, BD, Mississauga, ON, Canada).  Neutrophil isolation was performed at 
room temperature (20-22°C) immediately after blood collection.  The blood was allowed to 
separate into plasma and red cell fractions for 30-45 min at room temperature.  Plasma was 
layered onto 10 ml Ficoll-Paque™ Plus (GE Healthcare, Mississauga, ON, Canada) and 
centrifuged for 30 min at 400 x g.  The subsequent pellet, containing erythrocytes and 
granulocytes, was retained after aspirating the supernatant and washed with Hank’s Buffered Salt 
Solution (pH 7.4, HBSS) without phenol, magnesium, or calcium for 10 min at 200 x g.  
Erythrocytes were lysed with 2 ml sterile hypotonic distilled water with pH of 7.4 for 25 s and 
restored to normotonicity with an equal volume hypertonic (2x) HBSS.  Cells were washed 3 
times with HBSS at 200 x g for 10 min, suspended in culture medium (Roswell Park Memorial 
Institute (RPMI) 1640 medium containing 10% fetal bovine serum, 2 mM L-glutamine, 100 
IU/ml penicillin, 50 μg/ml streptomycin, and 25 mM Hepes, Lonza BioWhittaker®, VWR, 
Edmonton, AB, Canada), assessed for viability using Trypan blue staining, and counted with a 
hemocytometer.  Cell purity was determined on cytology preparations made with a 
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cytocentrifuge  (Shandon Cytospin 4, Thermo Scientific, Waltham, MA, USA) at 1000 rpm for 4 
min with medium acceleration and stained with a modified Giemsa stain (Hemacolor® EMD 
chemical, Gibbstown, NJ, USA).  
5.3.4 Neutrophil culture 
For ex vivo experiments, neutrophils were suspended in culture medium in plastic multi-well cell 
culture plates at a concentration of  2 x 106 cells/ml with or without lipopolysaccharide from 
Escherichia coli  (LPS, 1 μg/ml, Escherichia coli 055:B5, Sigma-Aldrich Canada, Oakville, ON, 
Canada) for 12 or 24 h at 37°C in 5% CO2. For in vitro experiments to assess the effect of 
neutrophil concentration on the occurrence of neutrophil apoptosis, neutrophils were cultured at 
concentrations of 2, 5, and 8 x 106 cells/ml for 12 and 24 h. For all experiments, neutrophils were 
taken out of culture, pelleted, and washed twice with HBSS at 300 x g for 8 min. prior to 
performing assays.   
5.3.5 Apoptosis assays 
5.3.5.1 Flow cytometry 
Neutrophils were stained with CF™488-conjugated Annexin V (AV) and propidium iodide (PI) 
per manufacturer’s instructions (CF™488A-Annexin V and PI Apoptosis Assay Kit, Biotium, 
Hayward, CA, USA).  Staining controls included unstained untreated cells, untreated cells 
stained with AV only, and untreated stained with PI only. A flow cytometer (CyFlow®, Partec, 
Swedesboro, NJ, USA) was used to count negatively stained (live) cells, AV stained (apoptotic) 
cells, or AV and PI stained (dead) cells. Flow cytometry data were analyzed with commercial 
software (FlowMax Software © Version 2.6, Quantum Analysis GmbH, Münster, Germany).  
The gated population was determined with unstained cells based on size (forward scatter) and 
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granularity (side scatter).  Quadrants were determined using untreated cells stained with only AV 
or PI. Data were acquired on at least 10,000 gated events.   
5.3.5.2 Caspase activity assay 
Caspase-3, -8, and -9 activities were indirectly measured using a commercially available kit per 
manufacturer’s instructions (Caspase-3, -8, or -9 Colorimetric Assay Kit, Biovision, Milpitas, 
CA, USA).  Caspase-3 activity was measured to determine overall apoptotic activity.  Caspase-8 
activity was measured to assess the contribution of the extrinsic pathway and Caspase-9 activity 
was measured to assess the contribution of the intrinsic pathway on the occurrence of neutrophil 
apoptosis.  One million neutrophils were lysed using the manufacturer’s lysis buffer following 
removal from culture and washed as described above. Cell lysates were stored at -80°C until 
processing.  Upon thawing, protein concentration in cell lysates was quantified using a 
commercial kit (DC™ Protein Assay, Bio-Rad Laboratories, Mississauga, ON, Canada). Cell 
lysates were incubated with a manufacturer’s reaction buffer containing dithiothreitol (DTT) and 
each Caspase’s substrate: DEVD-pNA (Caspase-3), IETD-pNA (Caspase-8), or LEHD-pNA 
(Caspase-9) in 96-well plates for 2 h at 37°C. Immediately after incubation, free pNA was 
quantified by measuring absorbance at 405 nm in a microtiter plate reader. Levels of free pNA 
were corrected for total protein concentration in cell lysates.  
5.3.6 Statistical analysis 
Data were analyzed with a commercial software package (Graphpad Prism, Graphpad Software, 
Inc. La Jolla, CA, USA) using non-parametric methods. For all comparisons, a P-value of < 0.05 
was considered significant.  The Wilcoxon matched-pairs signed rank test was used to compare 
data before and after the induction of colitis.  The Mann-Whitney U test was used to compare 
flow cytometry data between untreated and LPS-treated cells.  The Kruskal-Wallis rank test with 
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a Dunn’s multiple comparisons test was used to compare difference among in vitro treatment 
groups for LPS experiments.  The effect of neutrophil concentration on the occurrence of 
apoptosis was assessed with a Spearman’s rank correlation. 
5.4 Results 
5.4.1 SIRS developed in horses following the induction of oligofructose-induced colitis 
All horses developed severe diarrhea within 12 h of oligofructose administration.  In the six 
horses evaluated, heart rate and total white cell count were significantly increased from baseline 
values 18 h after the administration of oligofructose (heart rate: P = 0.03, total white cell count: 
P = 0.03, Figure 5.1).  There was a significant increase in the absolute number of neutrophils 
isolated per ml of blood after the induction of colitis compared to baseline in all 16 horses (P < 
0.0001, Figure 5.2).  None of the horses had measurable endotoxin (>0.25 EU/ml) before or 18 h 
after the induction of colitis.   
5.4.2 Ex vivo neutrophil apoptosis is delayed following the induction of colitis through reduced 
caspase activity 
Ex vivo neutrophil apoptosis was significantly reduced after 12 and 24 h in culture in neutrophils 
isolated after the induction of colitis compared to those isolated before the induction of colitis 
(12 h (n=10): P = 0.004, 24 h (n=16): P = 0.003, Figure 5.3).  Concomitantly, caspase-3, -8, and 
-9 activities were reduced after 12 h in culture in neutrophils isolated after the induction of colitis 
compared to those isolated before the induction of colitis (n =10, caspase-3: P = 0.004, caspase-
8: P = 0.02, caspase-9: P = 0.02, Figure 5.4).  
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5.4.3 LPS-delayed apoptosis is abrogated in neutrophils isolated following the induction of 
colitis 
After 24 h incubation, treatment with LPS in vitro significantly reduced the occurrence of 
apoptosis in neutrophils isolated from healthy horses prior to the induction of colitis (P <0.0001, 
Figure 5.5). However, in vitro LPS treatment failed to delay apoptosis in neutrophils isolated 
following the induction of colitis compared to untreated neutrophils (P = 0.83, Figure 5.5).  
Additionally, there was an increased occurrence of apoptosis in LPS-treated neutrophils isolated 
after the induction of colitis compared to LPS-treated neutrophils isolated before the induction of 
colitis (P = 0.013, Figure 5.5).   
5.4.4 Equine neutrophil apoptosis is delayed by increased concentration in vitro 
Increasing neutrophil concentration was significantly correlated with a reduced occurrence of 
apoptosis in vitro after 12 or 24 h in culture (12 h: r = -0.67, P < 0.0001, 24 h: r = -0.54, P = 
0.004, Figure 5.6). 
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Figure 5.1. Heart rate and total white blood cell count for 6 horses before and 18 h after the 
administration of oligofructose.  
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Figure 5.2 Total neutrophil count increased following the induction of colitis. Blood was 
collected for neutrophil isolation immediately before and 18 h after the administration of 
oligofructose.  Data were analyzed with a Wilcoxon matched-pairs signed rank test (n = 16).  
 
  
105 
 
 
 
Figure 5.3 Ex vivo neutrophil apoptosis was delayed following the induction of colitis.  . Blood 
was collected for neutrophil isolation immediately before and 18 h after the administration of 
oligofructose.  Data were analyzed with the Wilcoxon matched-pairs signed rank test (12 h: n = 
10, 24 h: n = 16). 
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Figure 5.4 Caspase-3, -8, and -9 activities were reduced in neutrophils isolated following the 
induction of colitis and 12 h incubation.  . Blood was collected for neutrophil isolation 
immediately before and 18 h after the administration of oligofructose.  Data were analyzed with 
the Wilcoxon matched-pairs signed rank test (n = 10). 
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Figure 5.5 LPS-delayed apoptosis was abolished in neutrophils isolated after the induction of 
colitis.  Data were analyzed with Kruskal-Wallis rank test with a Dunn’s multiple comparisons 
test (n = 16). 
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Figure 5.6 Neutrophil apoptosis is dependent upon concentration in vitro. Data were analyzed 
with a Spearman’s rank correlation. 
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5.5 Discussion  
In support of our hypothesis, ex vivo neutrophil apoptosis was significantly delayed following the 
induction of colitis by oligofructose overdose with a concomitant reduction in neutrophil caspase 
activity (Figure 5.6).  In the horses evaluated, SIRS developed, but plasma endotoxin was not 
detected.  We demonstrate that LPS treatment delays neutrophil apoptosis in vitro; but for the 
first time, we demonstrate that the effect of in vitro LPS treatment was abolished in neutrophils 
isolated after the induction of colitis.  In addition, we demonstrate that the occurrence of 
neutrophil apoptosis is dependent on concentration in vitro. 
Ex vivo neutrophil apoptosis was clearly delayed following the induction of colitis and 
SIRS, which is similar to what has been reported in the human literature (Fanning et al. 1999, 
Jimenez et al. 1997, Paunel-Görgülü et al. 2009, Shang et al. 2007). The cause of SIRS-related 
delayed neutrophil apoptosis may be multifactorial and is still under investigation.  However, 
sepsis and exposure to endotoxin is a well-established cause of delayed neutrophil apoptosis in 
species other than the horse (Brazil et al. 2014, Colotta et al. 1992, Milot et al. 2012, Paunel-
Görgülü et al. 2009, Sano et al. 2005).  Sepsis in humans results in a significant systemic 
inflammatory response, similar to what occurs in horses with oligofructose-induced colitis.  
Horses that are overdosed with oligofructose demonstrate signs of systemic inflammation in 
addition to severe colitis, which are generally attributed to endotoxemia and bacterial 
translocation through a compromised intestinal epithelial barrier (Senior et al. 2011).   
In this study, all horses, where parameters were evaluated, developed SIRS; however, 
measurable endotoxin was not detected in the same horses.  We cannot rule out that the horses in 
this study were not experiencing endotoxemia as the correct time point for measurable endotoxin 
load may have been missed due to endotoxin concentrations being measured at a single time 
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point.  In addition, endotoxin is rapidly cleared from the circulating blood volume, potentially 
making it difficult to detect when blood is collected from a peripheral site at a single time point 
(Fessler et al. 1989).  Also, the exact concentration of endotoxin required to activate circulating 
neutrophils in vivo and cause delayed ex vivo apoptosis is unknown. However, additional 
mechanisms other than endotoxemia could have contributed to the ex vivo delayed neutrophil 
apoptosis observed herein. 
Caspase-3, -8, and -9 activities were reduced in neutrophils isolated following the 
induction of colitis and cultured for 12 h.  Similarly, humans diagnosed with sepsis have reduced 
neutrophil capsase-3 and -9 activities that contribute to delayed ex vivo neutrophil apoptosis 
(Paunel-Görgülü et al. 2009, Taneja et al.2004).  The reduction in both caspase-8 (extrinsic 
initiator caspase) and caspase-9 (intrinsic initiator caspase) indicates that both the extrinsic and 
intrinsic pathways of neutrophil apoptosis are affected in neutrophils isolated from horses 
experiencing oligofructose-induced colitis.  We have found a similar reduction in caspase-3, -8, 
and -9 activities in neutrophils isolated from horses following the induction of intestinal ischemia 
and reperfusion (Chapter 4).  In contrast, our data show that in vitro LPS-delayed equine 
neutrophil apoptosis primarily affects the intrinsic pathway of apoptosis, ultimately resulting in 
reduced caspase-9 activity (Anderson et al. unpublished data).  Taken together, our results 
suggest that additional unknown factors other than endotoxin exposure are contributing to 
delayed equine neutrophil apoptosis in vivo. Additional investigation is necessary to further 
elucidate the mechanism of delayed neutrophil apoptosis in horses experiencing a systemic 
inflammatory response due to colitis. 
Interestingly, in vitro LPS treatment failed to delay apoptosis in neutrophils isolated 
following the induction of colitis.  One reasonable explanation, which requires further 
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investigation, is that neutrophils were exposed to LPS in vivo and then developed tolerance, 
which abrogated the effects of LPS in vitro. Tolerance by immune cells is thought to prevent an 
overzealous, detrimental immune response and leads to the development of a compensatory anti-
inflammatory response syndrome or CARS (Bone 1996, Cavaillon and Adib-Conquy 2006, 
Kopanakis et al. 2013, Medvedev et al. 2006).  Much less is known about LPS tolerance in 
neutrophil biology compared to other immune cells, such as macrophages and monocytes.  
Additionally, the concept of tolerance to endotoxin is well-accepted by equine researchers, 
however the mechanisms behind this phenomenon have not been thoroughly investigated (Allen 
et al. 1996). 
The induction of LPS tolerance in neutrophils is associated with reduced TLR4 surface 
expression and results in diminished neutrophil function, but maintenance of a pro-inflammatory 
phenotype (Parker et al. 2005).  Similar to our results, neutrophil function in response to LPS 
stimulation in vitro was dampened in neutrophils isolated from septic humans (McCall et al. 
1993).  In contrast, another study demonstrated that activated neutrophils isolated from the lungs 
of horses with recurrent airway obstruction express high levels of TLR4 and retain the ability to 
respond to LPS ex vivo (Aharonson-Raz et al. 2012). It is possible that there is a difference in 
neutrophil tolerance to LPS when neutrophils migrate into tissues compared to those in 
circulation. 
Endotoxin tolerance can also provide protection against non-endotoxin inflammatory 
disease processes, such as thermal or ischemia and reperfusion injury (Colleti et al. 1994, He et 
al. 1992).  In these scenarios, inflammatory cytokine concentrations, such as TNF-α, and 
physical manifestations of inflammation are reduced with pre-LPS exposure, but the underlying 
mechanisms are unknown at the cellular and molecular level (Colleti et al. 1994, He et al. 1992).  
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Intracellular signaling during inflammatory processes is complex, but also redundant allowing 
for cross-activation of many cell processes.  It is likely that multiple factors play a role in 
inflammation-delayed neutrophil apoptosis.  Taken together, neutrophil function is altered by 
pre-treatment with LPS.  To the authors’ knowledge, this is the first study in any species 
demonstrating a tolerogenic response to in vitro LPS-delayed neutrophil apoptosis.   
It is possible that the delayed ex vivo neutrophil apoptosis observed in the horses with 
colitis in this study was due to increased neutrophil concentration and density in vivo, as these 
factors have been shown to delay apoptosis in vitro (Hannah et al. 1998, Attalah et al. 2012).    
Indeed, all of the horses in this study had a significant increase in circulating neutrophil 
concentration following the induction of colitis. To the authors’ knowledge, this mechanism of 
delayed apoptosis has not been explored using an in vivo inflammation model.  An inflammation 
model introduces many confounding variables that make it less than ideal to study this 
mechanism of delayed neutrophil apoptosis in vivo; however, it more closely mimics a true 
clinical scenario.  In live animals, concentration-dependent delay in neutrophil apoptosis may be 
due to dysfunction of neutrophil adhesion genes as is observed in profound neutrophilia that 
occurs in bovine leukocyte adhesion deficiency disease (Nagahata et al. 2004).  
  In conclusion, ex vivo neutrophil apoptosis was delayed following the induction of 
colitis and SIRS in horses.  The role of delayed neutrophil apoptosis in the development of SIRS 
deserves further study in the horse as a potential therapeutic target, similar to what is already 
being performed in human medicine.  The modulation of neutrophil apoptosis could prove to 
reduce inflammation and promote the resolution of inflammation all at once, mitigating the 
effects of an overzealous and life-threatening inflammatory response. 
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Figure 5.7 Potential mechanism for delayed ex vivo equine neutrophil apoptosis following the 
induction of colitis. 
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5.6 Contineo to Chapter 6 
After determining that neutrophil apoptosis was delayed ex vivo following the induction 
of inflammation secondary to gastrointestinal insult, we were interested in exploring mechanisms 
to modulate neutrophil apoptosis.  To our knowledge, the effect of co-incubation of apoptotic 
neutrophils with freshly isolated neutrophils has never been evaluated for its contribution on 
acceleration of neutrophil apoptosis in vitro.  Therefore, a starting point was to determine if there 
were survival or non-survival signals that occur among neutrophil in the presence of apoptotic or 
aged neutrophils in vitro by assessing the occurrence of neutrophil apoptosis with co-incubation 
with 24 h-aged neutrophils.  A similar phenomenon has been demonstrated for concentration-
delayed neutrophil apoptosis where culture of freshly isolated neutrophils in supernatants from 
highly concentrated aged neutrophils prolonged lifespan due to a “community effect” (Atallah et 
al. 2012). 
In addition, we were interested in evaluating the effect of apoptotic neutrophils on 
neutrophil lifespan with concurrent LPS treatment or neutrophils isolated from horses 
experiencing systemic inflammation.  The administration of apoptotic neutrophils to mice 
experiencing endotoxic shock reduced inflammation and improved survival due to an as yet to be 
defined mechanism (Ren et al. 2008).  The effect of administering apoptotic neutrophils on ex 
vivo neutrophil survival was not specifically evaluated in that study, but it is possible that the 
administration of apoptotic neutrophils could cause increased apoptosis of circulating 
neutrophils, accounting for the measured anti-inflammatory effects.  
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CHAPTER 6: LPS- OR SYSTEMIC INFLAMMATION-
DELAYED EQUINE NEUTROPHIL APOPTOSIS IS NOT 
AFFECTED BY CO-INCUBATION WITH APOPTOTIC 
NEUTROPHILS   
6.1 Abstract  
Delayed neutrophil apoptosis may contribute to the development of a systemic inflammatory 
response syndrome (SIRS) in horses.  Modulation of neutrophil apoptosis may prove to be an 
effective treatment, but requires investigation.  We hypothesized that incubation of freshly 
isolated equine neutrophils with 24 h-aged autologous neutrophils would increase the occurrence 
of neutrophil apoptosis in vitro and rescue the delay in neutrophil apoptosis induced by LPS and 
inflammation.  Neutrophils were isolated and placed into culture for 24 h at a low concentration 
(5x105 cells/ml) to induce apoptosis.  Freshly isolated neutrophils from healthy horses were 
added to the 24 h-aged neutrophils with or without 1 μg/ml lipopolysaccharide (LPS).  In another 
experiment, freshly isolated neutrophils from horses with oligofructose-induced colitis were 
added to the 24 h-aged neutrophils.  The occurrence of apoptosis was assessed with Annexin V 
and propidium iodide staining and flow cytometric quantification after 24 h in culture.  
Neutrophil apoptosis was delayed in LPS-treated neutrophils and neutrophils isolated from 
horses after the induction of colitis (LPS: P = 0.0003, colitis: P = 0.03), but there was no effect 
of co-incubation with 24 h-aged neutrophils on the occurrence of apoptosis. Based on these 
results, apoptotic neutrophils do not appear to accelerate the occurrence of neutrophil apoptosis 
in vitro.    
6.2 Introduction 
Though not specifically studied in the horse, delayed neutrophil apoptosis contributes to 
collateral damage to tissues and delays macrophage-driven resolution of apoptosis, thereby 
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propagating an inflammatory response (Wright et al. 2010, Lucas et al. 2003).  We have 
demonstrated that neutrophil apoptosis is delayed ex vivo in two separate intestinal inflammation 
models (Anderson et al. unpublished data).  Horses subjected to these models developed clinical 
signs consistent with systemic inflammatory response syndrome (SIRS), including elevated heart 
rate, elevated neutrophil counts, and elevated body temperature. 
Typically, horses that develop SIRS are treated with non-specifically acting non-steroidal 
anti-inflammatory drugs (NSAIDs) that may reduce inflammation, but may also delay the 
resolution of inflammation.  Specifically, prostaglandin (PG) D2 and PGJ2, products of the 
arachidonic acid pathway that are inhibited by NSAID administration, have been shown to 
promote neutrophil apoptosis through inhibition of nuclear-factor kappa B (NF-κB, Ward et al. 
2004).  Therefore, administering NSAIDs during an inflammatory response may contribute to a 
prolonged neutrophil lifespan, delaying the resolution of inflammation.   
Designing therapeutics that modulate neutrophil apoptosis may serve as an effective 
method to control an inflammatory process (Savill et al. 2002).  Data from mice and human 
studies show that administration of apoptotic neutrophils into in vivo inflammation models 
modulates an inflammatory response (Ren et al. 2008, Morrison et al. 2013).  Specifically, Ren et 
al. (2008) demonstrated that administering apoptotic neutrophils up to 24 h after inducing 
endotoxic shock in mice reduced circulating pro-inflammatory cytokines, neutrophil infiltration 
in target organs, and serum LPS concentrations.  Thus far, similar in vitro or in vivo studies have 
not been performed in the horse. 
The determination of neutrophil lifespan is complex and is significantly affected by a 
neutrophil’s environment (Fox et al. 2010).  However, to the authors’ knowledge, it is unknown 
whether apoptotic neutrophils can influence the lifespan of non-apoptotic neutrophils in vitro.  
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We hypothesized that co-incubation of 24 h-aged equine neutrophils that have begun the process 
of apoptosis would increase the occurrence of apoptosis in freshly isolated equine neutrophils.  
Additionally, we hypothesized that 24 h-aged neutrophils would rescue LPS- and inflammation-
delayed neutrophil apoptosis.   
6.3 Materials and Methods 
6.3.1 Animals, model of systemic inflammation, and sample collection 
For in vitro experiments, blood was collected from healthy horses used for teaching purposes at 
the Western College of Veterinary Medicine (n=12).  Six healthy research horses were used for 
creating a model of systemic inflammation using an overdose of oligofructose (OGF) to induce 
colitis.  Briefly, horses were sedated with xylazine (0.5 mg/kg IV) and administered OGF (10 
g/kg bwt, OraftiP95®, Bene, Pemuco, Chile) dissolved in water via nasogastric tube intubation.   
Colitis developed over the next 12-15 hours.  Blood was sampled for ex vivo experiments 
immediately before and 18 h after challenge with oligofructose (OGF).  A physical examination 
was performed 1 h prior to and 18 h following OGF overdose.  Throughout the study period, 
horses were offered hay and water ad libitum. All procedures and experimental protocols were 
approved by the University of Saskatchewan Committee on Animal Care and Supply and the 
University of Saskatchewan Animal Research Ethics Board. 
6.3.2 Neutrophil isolation 
Neutrophils were isolated using a previously reported protocol with minor modification (Cook et 
al. 2009).  Blood was collected for neutrophil isolation aseptically from a jugular vein into 
vacuum tubes containing EDTA (Vacutainer™, BD, Mississauga, ON, Canada).  Isolation was 
performed at room temperature (20-22°C) immediately after blood collection.  The blood was 
allowed to separate into plasma and red cell fractions for 30-45 min at room temperature.  
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Plasma was layered onto 10 ml Ficoll-Paque™ Plus (GE Healthcare, Mississauga, ON, Canada) 
and centrifuged for 30 min at 400 x g.  The subsequent pellet, containing erythrocytes and 
granulocytes, was retained after aspirating the supernatant and washed with Hank’s Buffered Salt 
Solution (pH 7.4, HBSS) without phenol, magnesium, or calcium for 10 min at 200 x g.  
Erythrocytes were lysed with 2 ml sterile hypotonic distilled water for 25 s and restored to 
normotonicity with an equal volume hypertonic (2x) HBSS.  Cells were washed 3 times with 
HBSS at 200 x g for 10 min, suspended in culture medium (Roswell Park Memorial Institute 
(RPMI) 1640 medium containing 10% fetal bovine serum, 2 mM L-glutamine, 100 IU/ml 
penicillin, 50 μg/ml streptomycin, and 25 mM Hepes, Lonza BioWhittaker®, VWR, Edmonton, 
AB, Canada), assessed for viability using Trypan blue staining, and counted with a 
hemocytometer.  Cell purity was determined on cytology preparations made with a 
cytocentrifuge  (Shandon Cytospin 4, Thermo Scientific, Waltham, MA, USA) at 1000 rpm for 4 
min with medium acceleration and stained with a modified Giemsa stain (Hemacolor® EMD 
chemical, Gibbstown, NJ, USA).  
6.3.3 Neutrophil culture 
For all experiments, neutrophils were suspended in culture medium in plastic multi-well cell 
culture plates. To assess the effect of co-incubation of apoptotic neutrophils on the occurrence of 
freshly isolated neutrophils in vitro, neutrophils were first cultured at a concentration of 5 x 105 
cells/ml for 24 h to allow cells to become apoptotic (24-h autologous neutrophils).  Then freshly 
isolated neutrophils were cultured at a concentration of 2 x 106 cells/ml with no treatment, 
treatment with 1 μg/ml LPS (Escherichia coli 055:B5, Sigma-Aldrich Canada, Oakville, ON, 
Canada), co-incubation with 24 h-aged autologous neutrophils (1:8 ratio of aged:fresh 
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neutrophils), or co-incubation with 24 h-aged autologous neutrophils and 1 μg/ml LPS for 24 h at 
37°C in 5% CO2.  
For ex vivo experiments, neutrophils were isolated prior to OGF overdose and cultured at 
a concentration of 5  x105 cells/ml for 24 h to allow cells to become apoptotic (24-h autologous 
neutrophils) or a standard concentration 2x106 cells/ml to assess baseline occurrence of ex vivo 
apoptosis.  Neutrophils were isolated 18 h after OGF overdose, placed into culture at a 
concentration of 2 x 106 cells/ml, and left untreated or co-incubated with 24 h-aged autologous 
neutrophils for 24 h at 37°C in 5% CO2.  Prior to performing apoptosis assays, neutrophils were 
taken out of culture, pelleted, and washed twice with HBSS at 400 x g for 8 min.   
6.3.4 Determination of apoptosis 
Neutrophils were stained with CF™488-conjugated Annexin V (AV) and propidium iodide (PI) 
per manufacturer’s instructions (CF™488A-Annexin V and PI Apoptosis Assay Kit, Biotium, 
Hayward, CA, USA).  Staining controls included unstained untreated cells, untreated cells 
stained with AV only, and untreated stained with PI only. A flow cytometer (CyFlow®, Partec, 
Swedesboro, NJ, USA) was used to count negatively stained (live) cells, AV positively stained 
(apoptotic) cells, or AV and PI positively stained (dead) cells. Flow cytometry data were 
analyzed with commercial software (FlowMax Software © Version 2.6, Quantum Analysis 
GmbH, Münster, Germany).  The gated population was determined with unstained cells based on 
size (forward scatter) and granularity (side scatter).  Quadrants were determined using untreated 
cells stained with only AV or PI. Data were acquired on at least 10,000 gated events.   
6.3.5 Statistical analysis 
Data were analyzed with a commercial software package (Graphpad Prism, Graphpad Software, 
Inc. La Jolla, CA, USA). For all comparisons, a P-value of < 0.05 was considered significant. All 
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data were analyzed using non-parametric tests.  Differences among in vitro groups were assessed 
with a Kruskal-Wallis rank test with a Dunn’s multiple comparisons test. The Wilcoxon 
matched-pairs signed rank test was used to compare occurrence of neutrophil apoptosis before 
and after the induction of colitis.  The Mann-Whitney U test was used to compare untreated cells 
with cells co-incubated with 24-h autologous neutrophils in neutrophils isolated following the 
induction of colitis. 
6.4 Results 
6.4.1 Clinical data 
See Chapter 5 for clinical data results. 
6.4.2 Co-incubation of apoptotic equine neutrophils failed to rescue LPS- or systemic 
inflammation-delayed equine neutrophil apoptosis 
LPS treatment delayed in vitro apoptosis (P = 0.0003, Figure 6.1); however, co-incubation with 
24 h-aged neutrophils failed to rescue LPS-delayed neutrophil apoptosis (Figure 6.1).  When 
colitis and SIRS were induced, ex vivo neutrophil apoptosis was delayed compared to baseline (P 
= 0.03, Figure 6.2); but, co-incubation with 24 h-aged neutrophils had no effect on the 
occurrence of ex vivo neutrophil apoptosis before or after the induction of colitis and SIRS 
(Figure 6.2). There was no significant difference in concentration of cultured neutrophils among 
treatment types for the in vitro or ex vivo experiments (Figure 6.3). 
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Figure 6.1 Co-incubation of freshly isolated neutrophils with apoptotic neutrophils failed to 
abolish LPS-delayed apoptosis after 24 h in culture.  Data were analyzed with a Kruskal-Wallis 
rank test with a Dunn’s multiple comparisons test.  Bars represent median. Difference between 
letters indicates significant difference (P < 0.01). 
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Figure 6.2 Co-incubation of freshly isolated neutrophils with apoptotic neutrophils fails to 
abolish inflammation-delayed apoptosis after 24 h in culture.  Data in 6.2a were analyzed with a 
Wilcoxon matched-pairs signed rank test. Data in 6.2b were analyzed with a Mann-Whitney U 
test.  Bars represent median. 
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Figure 6.3 There was no difference in cell concentrations after 24 h incubation among treatments 
for in vitro experiments (a) or between treatments for ex vivo experiments (b) indicating that the 
24-h aged neutrophils could not have contributed to concentration-delayed apoptosis.  Data in 
figure 6.3a were analyzed with a Kruskal-Wallis rank test with a Dunn’s multiple comparisons 
test and data in figure 6.3b were analyzed with a Mann-Whitney U test.  Bars represent median. 
 
  
124 
 
6.5 Discussion 
In contrast to our hypothesis, co-incubation of neutrophils, both LPS-activated and inactivated, 
with 24 h-aged neutrophils failed to have an effect on the occurrence of apoptosis in vitro.  In 
addition, there was no difference in cell concentrations upon treatment with apoptotic 
neutrophils, indicating that an artificial increase in percentage of apoptotic cells was negligible.   
To the authors’ knowledge, this is the first report to evaluate the effect of co-incubation 
of aged neutrophils with freshly isolated neutrophils in order to determine the effect on the 
occurrence of neutrophil apoptosis in vitro.  We chose to evaluate the effect of co-incubation of 
apoptotic neutrophils with fresh neutrophils because there is potentialp intercellular signaling 
that could occur amongst a population of neutrophils to control lifespan.  Previous research has 
demonstrated that increased concentration or increased density of neutrophils significantly 
prolongs neutrophil lifespan (Attalah et al. 2012, Hannah et al. 1998).  We have confirmed this 
finding with equine neutrophils (Anderson et al. unpublished data).  For this reason, we chose to 
incubate our originally isolated neutrophils in this study at a low concentration and low density 
to rapidly promote apoptosis (data not shown).  Attalah et al. 2012 demonstrated that human 
neutrophil apoptosis was delayed by increasing concentration in vitro via proteins S100A8 and 
S100A9, which were released into the supernatant to initiate intercellular signaling and the 
promotion of neutrophil survival. Therefore, we thought it possible that an opposite effect could 
occur whereby neutrophil apoptosis could be induced by co-incubating freshly isolated 
neutrophils with 24 h-aged neutrophils in their original media.  However, that hypothesis was 
disproven by our results. 
The use of apoptotic neutrophils to treat LPS-induced inflammation has shown promising 
results in mice (Ren et al. 2008).  The mechanism underlying the effect of administering 
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apoptotic neutrophils in the face of LPS challenge is primarily due to modulation of monocyte 
cytokine secretion (Fadok et al. 1998, Ren et al. 2008).  However, another mechanism by which 
apoptotic neutrophils modulate an inflammatory response may involve the neutralization of LPS 
(Ren et al. 2008).  While apoptotic neutrophils have the capacity to bind LPS, they will lack the 
ability to de-granulate making this a potential method of neutralizing LPS in vivo.  Co-incubation 
with apoptotic neutrophils has also been shown to reduce the pro-inflammatory functions of 
neutrophils, as measured by reactive oxygen species (ROS) production, in the face of LPS 
treatment (Esman et al. 2010).  
From the results of this study, it is evident that apoptotic neutrophils do not induce 
apoptosis in normal neutrophils, LPS-activated freshly isolated neutrophils, or neutrophils 
isolated from horses experiencing systemic inflammation due to colitis suggesting that this 
mechanism is not important in modulating neutrophil lifespan.  However, additional work needs 
to be performed to evaluate the effect of apoptotic equine neutrophils on macrophage function 
and LPS neutralization in vitro and in vivo. 
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CHAPTER 7: SUPPLEMENTAL DATA 
7.1 Abstract 
A horse from the sham celiotomy group for the third chapter of this thesis experienced severe 
acute aspiration pneumonia following general anesthesia.  Lung sections obtained from the horse 
were stained for hematoxylin and eosin, revealing severe suppurative aspiration pneumonia 
characterized by a marked accumulation of neutrophils into the affected portion of the lung.  
Immunohistochemical staining was performed against the anti-apoptotic protein A1 and anti-
calprotectin (MAC387) and revealed a marked expression of these proteins in neutrophils 
infiltrating the affected portions of the lung.  This is the first report evaluating apoptotic protein 
expression in a severe neutrophilic inflammatory condition in the horse. 
Accepted, in part, by the Journal of American Veterinary Medicine as a Pathology “What is 
Your Diagnosis?”  
 
7.2 Case Details 
An 8-year-old Quarter Horse gelding weighing 527-kg (1,161-lb) was placed under general 
anesthesia to undergo a research procedure via a ventral median celiotomy with approval by the 
institution’s animal care and ethics committee.  The horse was determined to be healthy by 
physical examination and complete blood count prior to surgery.  The horse was fasted, but 
allowed access to water, over night before the induction of anesthesia and received no pre-
operative treatments.   Following general anesthesia where a ventral midline celiotomy was 
performed, the horse had a prolonged recovery from anesthesia (1 h and 40 min.) and required 
considerable encouragement to stand.  Gastric contents were observed exiting from the nostrils 
during the early part of recovery. 
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Following recovery from anesthesia, the horse was moved to a stall for observation. 
Within 6 hours following recovery, the horse became febrile (102.1ºF), tachycardic (60 
beats/minute), tachypneic (28 breaths per minute), the mucous membranes became injected, and 
he became markedly depressed.  At 12 h post-operatively, his lung sounds became harsh on 
auscultation of the cranioventral thorax; and by 18 h post-operatively, harsh lung sounds could 
be heard throughout the entire thorax. A complete blood count performed 18 h post-operatively 
revealed a leukocytosis, neutrophilia with left shift, lymphopenia, and monocytosis. 
The horse was euthanized for the purpose of research and a necropsy was performed.  On 
gross examination, the cranial lobe and craniodorsal and caudodorsal parts of the caudal lobes of 
the right and left lung were firm, failed to collapse, discolored yellow and covered by an 
adherent layer of friable material (fibrin).  There was marked congestion of the caudal dorsal 
surface of both lungs.   On cut sections, feed material could be grossly observed within the large 
bronchi and marked separation of the interlobular septa (pulmonary edema) was present.   
On histology, alveoli within affected areas were filled with large numbers of viable and 
degenerate neutrophils, fine fibrilar eosinophilic material (fibrin), protein rich edema fluid, and 
small amounts of hemorrhage (Figure 7.1A).  Occasionally, alveoli were filled with cellular and 
nuclear debris (necrosis).  Alveolar septa were moderately congested, and frequently necrotic.  
Interlobular septa were markedly expanded and filled with fibrin, edema and a similar 
inflammatory population to that seen in alveoli.  Similar changes were present on the pleural 
surface of affected sections.  Airways were largely clear of material and epithelium was intact.  
These changes are consistent with a severe acute multifocal to coalescing fibrinonecrotizing, 
suppurative pneumonia with marked pulmonary edema and fibrinous pleuritis.   
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Immunohistochemical staining was performed using primary antibodies against B-cell 
lymphoma (Bcl2)-related protein A1 (Santa Cruz, CA, USA), an anti-apoptotic proteins of the 
Bcl2 family, and anti-human macrophage antibody (MAC387, AbD Serotec®, Raleigh, NC, 
USA) that binds to calprotectin, a protein present in many inflammatory cells including 
macrophages and neutrophils.  Affected lung sections had marked staining for both proteins in 
neutrophils (Figure 7.1B and 7.1C). 
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Figure 7.1 Photomicrographs of representative sections stained with hematoxylin and eosin (A) 
or with immunohistochemistry against the anti-apoptotic protein A1 (B) or anti-macrophage 
antibody MAC387 (C).    
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7.3 Discussion 
Regurgitation leading to aspiration of stomach contents during anesthesia is exceedingly 
rare in horses due to the unique muscular distribution within their esophagus and strong cardiac 
sphincter, which prevents regurgitation of stomach contents, unlike carnivores (Carpenter and 
Hall 1981, Cunningham 2002, Davies et al. 2015, Taylor and Clarke 2007).  However, it is 
common practice to induce a horse with an indwelling nasogastric tube for colic surgery to 
reduce the risk of aspiration from spontaneous gastric reflux that may occur from an overly 
distended stomach (Cunningham 2002, Taylor and Clarke 2007). 
In humans and dogs, reflux of gastric contents during anesthetic events is not uncommon 
and aspiration of gastric acid may cause acute lung injury (Galato and Raptopoulos 1995, Many 
et al. 1986, Suratt and Parsons 2006, Warner et al. 1993).  Acute lung injury (ALI) is defined 
clinically in veterinary patients by acute onset tachypnea and labored breathing, hypoxemia, 
evidence of pulmonary capillary leakage without increased pulmonary capillary pressure, and a 
known risk factor, such as SIRS, with or without evidence of diffuse pulmonary inflammation 
(Wilkins et al. 2007).  Some of the criteria listed above were either not assessed or not present in 
this case; so based on clinical signs, it is difficult to state that the horse was experiencing ALI.  
However, to the authors’ knowledge, ALI has never been reported in an adult horse in a clinical 
case.  Additionally, based on the authors’ research, it is possible that adult horses are highly 
resistant to developing clinically apparent ALI, as compared to other species and foals (Dunkel 
et al. 2007).  
Regardless, it is clear that this horse suffered from severe aspiration pneumonia, which 
resulted in a marked neutrophilic inflammatory response in the lung and a systemic 
inflammatory response syndrome (SIRS).  It has been shown that neutrophil apoptosis is delayed 
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upon activation with many substances (Fox et al. 2010).  The increased expression of the anti-
apoptotic protein A1 would suggest that the neutrophils infiltrating the lung in this case would be 
resistant to apoptosis.  Similarly, in mice, installation of LPS into the lung resulted in increased 
expression of A1in lung neutrophils (Kupfner et al. 201). In the horse presented here, A1 
expression was likely increased in neutrophils that had infiltrated into the lung due to neutrophil 
activation by the aspirated foreign material and gastric acid. The expression of anti-apoptotic 
proteins and other markers of apoptosis should be further evaluated in neutrophils taken from 
equine inflammatory models to further assess the contribution of delayed neutrophil apoptosis to 
inflammatory processes. 
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CHAPTER 8: DISCUSSION AND CONCLUSIONS 
8.1 General Discussion 
The goal of the research presented in this thesis was to investigate equine neutrophil lifespan in 
the face of inflammatory conditions. The majority of experiments were designed based on 
previously established protocols using human neutrophils, with additional experiments designed 
to investigate specific pathways of interest and the effect of inflammatory processes unique to 
the horse.  We report for the first time that equine neutrophils experience delayed apoptosis in 
the face of various inflammatory scenarios in vitro and in vivo.  
 Neutrophils have short lifespans that may be prolonged upon activation to allow them to 
neutralize threats to the body (Fox et al. 2010).  However, by prolonging their lifespan 
neutrophils potentiate an inflammatory process through release of their cytotoxic contents and 
production of reactive oxygen species (Jimenez et al. 1997).  At the same time, macrophage-
dependent resolution of inflammation is delayed when apoptotic neutrophils are unavailable for 
efferocytosis (Fadok et al. 1998, Huynh et al. 2002, Lucas et al. 2013).  The mechanisms by 
which neutrophil lifespan is prolonged during inflammatory processes is still under investigation, 
and is relatively unknown in the horse. 
 One of the most commonly used substances to activate neutrophils in vitro is the bacterial 
endotoxin, LPS.  In turn, LPS activation prolongs neutrophil lifespan in vitro by upregulating 
anti-apoptotic proteins of the Bcl2 protein family (Colotta et al. 1992, Jia et al. 2008, Milot et al. 
2012, Sweeny et al. 1998, Sano et al. 2005, Yamamoto et al. 1993).  However, an opposite effect 
of in vitro LPS treatment was recently demonstrated using equine neutrophils where neutrophils 
had increased occurrence of apoptosis with LPS treatment (Brazil et al. 2014). To assess the 
effect of LPS activation on equine neutrophil lifespan in vitro, experiments were designed to 
133 
 
measure the occurrence of neutrophil apoptosis in vitro using Annexin V and propidium iodide 
staining quantified with flow cytometry.  Additionally, the mechanisms of apoptosis involved 
with LPS-treated neutrophils were explored.   
 As expected, LPS treatment delayed the occurrence of equine neutrophil apoptosis in a 
concentration-dependent manner.  Though we were unable to demonstrate the involvement of 
specific Bcl2 proteins due to difficulties finding equine-compatible antibodies, we added novel 
insight into mechanisms that contribute to LPS-delayed neutrophil apoptosis by confirming 
TLR4 involvement and measuring reduced caspase-9 activities in equine neutrophils treated with 
LPS in vitro (Figure 3.8).   
 Neutrophil apoptosis is delayed in human patients suffering from sepsis, which may be 
attributed to endotoxemia (Jimenez et al. 1997).  However, sepsis is also invariably associated 
with the development of SIRS, in which neutrophil apoptosis is delayed (Fanning et al. 1999, 
Jimenez et al. 1997, Shang et al. 2007).  We used two equine models of intestinal inflammation 
that are associated with the development of endotoxemia and SIRS to evaluate neutrophil 
lifespan in vivo.  Because apoptotic neutrophils are rapidly removed from the circulation, it is 
necessary to isolate neutrophils activated in vivo and culture them to assess the length of their 
lifespan.  We failed to measure endotoxin in plasma from horses undergoing jejunal ischemia 
and reperfusion or oligofructose-induced colitis.  However, it is possible that our method of 
detection plasma endotoxin was ineffective and circulating endotoxin was present.  Regardless, 
horses with intestinal inflammation developed SIRS and ex vivo neutrophil apoptosis was 
delayed through reduced intrinsic and extrinsic caspase activity following the induction of 
intestinal inflammation.  
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 The mechanism underlying delayed neutrophil apoptosis in these horses may be 
independent of endotoxemia, and may instead involve a cell concentration effect because data 
show that increased concentration of neutrophils delays apoptosis in vitro.  We also demonstrate 
for the first time that the depletion of pulmonary intravascular macrophages, through 
administration of parenteral gadolinium chloride, rescues delayed ex vivo neutrophil apoptosis 
associated with intestinal ischemia and reperfusion injury. PIMs are a unique type of macrophage 
that, similar to Kupffer cells in the liver, are attached intimately to the endothelium of the 
alveolar capillaries and are exposed to the entire blood volume as it passes through the lung for 
oxygenation.  Their proposed function is to sample the blood searching for pathogen- or danger-
associated molecular patterns in order to mount an inflammatory response (Atwal and McDonell 
2005).  In addition, because of their attachment to the endothelium, it is possible that PIMs are 
involved in vascular inflammatory responses (Aharonson-Raz and Singh 2010). Their role in 
lung disease has been investigated in multiple species; however, their involvement in systemic 
inflammatory responses has not been studied. 
The inflammatory (TNF-α and IL-1β) and anti-inflammatory (IL-10 and TGF-β) cytokine 
profile in PIM-depleted horses experiencing intestinal IR was significantly different than horses 
only experiencing IR, where PIM-depleted horses had a greater inflammatory response.  These 
results could, in part, explain the difference measured in ex vivo neutrophil lifespan.  
Specifically, TNF-α is important in regulating neutrophil apoptosis (Fox et al. 2010, Murray et 
al. 1997, Salamone et al. 2001).  Early or high concentration TNF-α exposure stimulates 
neutrophil apoptosis (Fox et al. 2010, Murray et al. 1997, Salamone et al. 2001).  Indeed, Brazil 
et al. demonstrated enhanced apoptosis with early treatment (8 h) with equine recombinant TNF-
α, but no effect after 20 h treatment (Brazil et al. 2014).  However, late survival (after 12 h) is 
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promoted simultaneously through activation of the NF-κB pathway and subsequent up-regulation 
of the anti-apoptotic members of the Bcl-2 family, particularly A1 (Cross et al. 2008). Plasma 
TNF-α concentrations increased earlier in PIM-depleted horses, which would potentially induce 
apoptosis earlier in circulating neutrophils as evidenced in our experiment. Further experiments 
are necessary to evaluate the effect of TNF-α on equine neutrophil apoptosis.  
Delayed neutrophil apoptosis is a self-propagating phenomenon.  Based on the results 
from the in vivo models presented in this thesis, a potential scenario involves the exposure of 
neutrophils to a signal that delays their apoptosis (e.g. LPS), which, in conjunction with 
increased entry of new neutrophils into circulation, increases their concentration in the system, 
further prolonging their life through a currently undetermined mechanism.  The prolongation of 
neutrophil lifespan then propagates an inflammatory response and contributes to the 
development of SIRS. 
8.2 Future Directions 
We still have insufficient understanding of neutrophil lifespan during inflammatory conditions in 
the horse (and other species) to achieve the ultimate goal of designing targeted therapeutics to 
modulate neutrophil apoptosis as a multimodal approach to treating inflammatory conditions.  
Many new questions were generated by the results presented in this thesis, which may be 
answered through further experiments. 
A critical subsequent experiment must be performed to answer one of the main questions 
generated from the results of the in vivo models reported herein:  Does endotoxemia cause 
delayed ex vivo neutrophil apoptosis?  This experiment would evaluate the occurrence of equine 
neutrophil apoptosis before and after the administration of intravenous LPS.  This model will 
remove confounding etiologies, such as local organ injury, from the development of a systemic 
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inflammatory response.  At the same time, neutrophil tolerance may be assessed by performing a 
second in vivo LPS challenge or treating neutrophils isolated following LPS challenge with LPS 
in vitro.  Similarly, the effect of concomitantly depleting PIMs using gadolinium chloride could 
potentially provide additional information on their role in determining neutrophil lifespan during 
systemic inflammation due to endotoxemia.  Outcomes of these experiments need to focus on 
proteins involved in intracellular signaling of inflammation and apoptotic pathways, ideally 
using multiplex technology to assess multiple genes of interest over multiple time points. 
8.3 Limitations of the Studies 
Though we chose models that mimic clinical scenarios of endotoxemia, we failed to measure 
endotoxin in any horses at any time points.  As previously discussed, it is possible that we 
missed the appropriate time point for measurement, so ideally endotoxin concentrations should 
have been measured over time.  Also, it is possible that endotoxin is removed so rapidly from the 
blood that it is difficult to measure.  Therefore, we would recommend using a non-terminal LPS 
infusion SIRS model to further evaluate the effects of LPS on in vivo neutrophil lifespan.   
 Additionally, more horses are required to lend sufficient power to the data presented in 
the intestinal ischemia and reperfusion model chapter.  It is always a struggle to justify the 
sacrifice of animals to provide adequate power to a study; however, based on the interesting 
results with gadolinium chloride treatment, the sacrifice of additional animals is warranted to 
fully evaluate the effects of this treatment. 
8.4 Concluding remarks 
The study of delayed neutrophil apoptosis is a highly complex process that cannot be completed 
by simply exposing neutrophils to various cytokines, bacterial products, or conditions.  In vivo 
neutrophil lifespan is most likely also affected by other immune cell signaling, particularly from 
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macrophages and monocytes.  There is a distinct void in the literature on innate and adaptive 
immune cell signaling and its effect on neutrophil lifespan; therefore, this area requires 
additional study in all species. 
Because delayed neutrophil apoptosis is an important process for the body to maintain a 
large effector cell population to deal with threats to the body, redundant mechanisms likely exist.  
Within this thesis, we focused on very specific causes for delayed neutrophil apoptosis. 
However, the major conclusion one should garner from this body of work is that neutrophil 
apoptosis was delayed in inflammatory conditions originating from the gastrointestinal tract, and 
the delay in neutrophil apoptosis may be an important contributor to SIRS.  
The contribution of delayed neutrophil apoptosis on the propagation and resolution of 
inflammation is still under investigation.  Intuitively, promoting neutrophil apoptosis would 
seem to reduce inflammation, but at what cost to the effectiveness of the innate immune 
response? The ability to induce neutrophil apoptosis, whether locally or systemically, may prove 
to be an important therapeutic target in treating inflammatory diseases; however, the timing of 
promoting neutrophil apoptosis will be critical in developing effective treatment regimens. 
This body of work contributes significantly to the literature on the equine innate immune 
system.  Despite the horses’ propensity to experience life-threatening inflammation, there is a 
distinct void in research into the equine innate immune system.  Rather, researchers focus on 
treatment regimens that have been extrapolated from human medicine, where similar basic 
knowledge on the innate immune response may be lacking.  Before effective treatments can be 
developed, understanding of the equine innate immune response must be more complete.  
Additionally, we propose that the horse could serve as a valuable model for studying 
inflammatory diseases in humans, specifically sepsis and endotoxemia. 
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8.5 Conclusions 
 LPS treatment delays equine neutrophil apoptosis in vitro through reduced caspase-9 
activity and TLR4 signaling. 
 Ex vivo equine neutrophil apoptosis is delayed following the induction of intestinal 
inflammation and SIRS through reduced caspase activity. 
 Pulmonary intravascular macrophages are involved in modulating systemic inflammatory 
cytokine concentrations that may affect neutrophil apoptosis. 
 Equine neutrophil apoptosis is delayed by increased cell concentration in vitro. 
 Equine neutrophils become refractory to the in vitro effect of LPS on their lifespan 
following the induction of SIRS in vivo. 
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8.1 Pathophysiology of delayed equine neutrophil apoptosis originating from intestinal 
inflammation. 
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